Processing 00000000.tx.1: Effects of Neprilysin Chimeric Proteins Targeted to Subcellular Compartments on Amyloid Peptide Clearance in Primary Neurons* Emi Hama, Keiro Shirotani, Nobuhisa Iwata, and Takaomi C. 

Phrase: "Effects of Neprilysin Chimeric Proteins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "Targeted to Subcellular Compartments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1185625:Compartments [Body Space or Junction]
   770   C1382196:Compartments [Natural Phenomenon or Process]
   770   C1521840:Targeted [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]
   737 E C2986730:Compartment [Spatial Concept]

Phrase: "on Amyloid Peptide Clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "in Primary Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "* Emi Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1295018:HAMA [Laboratory Procedure]
   861   C3541258:HAMA [Intellectual Product]

Phrase: "Keiro Shirotani,"

Phrase: "Nobuhisa Iwata,"

Phrase: "and"

Phrase: "Takaomi C."
Processing 00000000.tx.2: Saido From the Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan Received for publication, February 20, 2004 , and in revised form, March 26, 2004.  

Phrase: "Saido From the Laboratory"

Phrase: "for Proteolytic Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "RIKEN Brain Science Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "2-1 Hirosawa,"

Phrase: "Wako-shi,"

Phrase: "Saitama 351-0198,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "February 20,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "March 26,"

Phrase: "2004."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Neprilysin (NEP) is a rate-limiting amyloid peptide (A)-degrading enzyme in the brain. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Neprilysin (NEP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "is"

Phrase: "a rate-limiting amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A)-degrading enzyme in the brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
Processing 00000000.tx.4: We demonstrated previously that overexpression of neprilysin in primary cortical neurons remarkably decreased not only extracellular but also intracellular A levels. 

Phrase: "We"

Phrase: "demonstrated"

Phrase: "previously"

Phrase: "that overexpression of neprilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in primary cortical neurons remarkably"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   812   C0001613:Cortical [Body Part, Organ, or Organ Component]
   812   C0007776:Cortical [Body Part, Organ, or Organ Component]
   812   C0022655:Cortical [Body Part, Organ, or Organ Component]
   812   C0027882:Neurons [Cell]
   812   C0205225:Primary [Qualitative Concept]
   812   C0439631:Primary [Therapeutic or Preventive Procedure]
   756 E C0234875:bark [Organism Attribute]
   756 E C2700441:Bark [Plant]
   729 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   729 E C0521390:Neuronal [Immunologic Factor]
   729 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "not only extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521119:Extracellular [Cell Component]

Phrase: "but"

Phrase: "also intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175996:intracellular [Cell Component]
   861   C0178719:Intracellular [Spatial Concept]

Phrase: "A levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.5: To investigate the subcellular compartments where neprilysin degrades A most efficiently, we expressed neprilysin chimeric proteins containing various subcellular compartment-targeting domains in neurons. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the subcellular compartments where neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "degrades"

Phrase: "A most efficiently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "we"

Phrase: "expressed"

Phrase: "neprilysin chimeric proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "various subcellular compartment-targeting domains in neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.6: Sec12-NEP, -galactoside 2,6-sialyltransferase-NEP, transferrin receptor-NEP, and growth-associated protein 43-NEP were successfully sorted to the endoplasmic reticulum, trans-Golgi network, early/recycling endosomes, and lipid rafts, respectively. 

Phrase: "Sec12-NEP, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "galactoside 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016956:galactoside [Carbohydrate]

Phrase: "6-sialyltransferase-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "transferrin receptor-NEP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "and"

Phrase: "growth-associated protein 43-NEP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366499:NEPRILYSIN [Gene or Genome]
   771   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "were"

Phrase: "successfully"

Phrase: "sorted to the endoplasmic reticulum,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0237886:sorted [Mental Process]
   760   C0700314:sorted [Cell Function]
   760   C1947906:Sorted [Activity]

Phrase: "trans-Golgi network,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "early/recycling endosomes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0887883:Early endosome [Cell Component]
   867   C2262706:recycling endosome [Cell Component]
   827   C0034850:Endosomes [Cell Component]
   827   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "lipid rafts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167250:lipid rafts [Cell Component]
   827   C0336849:Raft [Manufactured Object]

Phrase: "respectively."
Processing 00000000.tx.7: We found that intracellularly, wild-type neprilysin and all the chimeras showed equivalent A40-degrading activities. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that intracellularly,"

Phrase: "wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "all the chimeras"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008109:Chimeras [Organism]
   966 E C1318484:Chimera [Disease or Syndrome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "equivalent A40-degrading activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.8: A40 was more effectively cleared than A42, and this tendency was greater for intracellular A than for extracellular A. 

Phrase: "A40"

Phrase: "was"

Phrase: "more effectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "cleared than A42,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0521097:cleared [Functional Concept]
   756 E C2963144:Clear [Qualitative Concept]

Phrase: "and"

Phrase: "this tendency"

Phrase: "was"

Phrase: "greater for intracellular A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "than"

Phrase: "for extracellular A."
Processing 00000000.tx.9: Wild-type and trans-Golgi network-targeted ST-NEP cleared more intracellular A42 than the other chimeras. 

Phrase: "Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "trans-Golgi network-targeted ST-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "more intracellular A42 than the"

Phrase: "other chimeras."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008109:Chimeras [Organism]
   966 E C1318484:Chimera [Disease or Syndrome]
Processing 00000000.tx.10: Wild-type neprilysin cleared extracellular A more effectively than any of the chimeras, among which endoplasmic reticulum-targeted Sec12-NEP was the least effective. 

Phrase: "Wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]

Phrase: "A more effectively than any of the chimeras,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0008109:Chimeras [Organism]
   711 E C1318484:Chimera [Disease or Syndrome]

Phrase: "among which endoplasmic reticulum-targeted Sec12-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "was"

Phrase: "the least effective."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280519:effective [Qualitative Concept]
   861   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.11: These observations indicate that different intracellular compartments may be involved in the metabolism of distinct pools of A (A40 and A42) to be retained or recycled intracellularly and to be secreted extracellularly, and that the endogenous targeting signal in wild-type neprilysin is well optimized for the overall neuronal clearance of A.  

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that different intracellular compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the metabolism of distinct pools of A (A40"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   739   C0025519:Metabolism [Organism Function]
   739   C0025520:metabolism [Functional Concept]
   739   C0337051:pools [Geographic Area]
   739   C1314939:Involved [Functional Concept]
   706 E C1509144:pool [Clinical Attribute]
   706 E C2349200:Pool [Functional Concept]

Phrase: "and"

Phrase: "A42"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "or"

Phrase: "recycled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:recycled [Human-caused Phenomenon or Process]

Phrase: "intracellularly"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "extracellularly,"

Phrase: "and"

Phrase: "that"

Phrase: "the endogenous targeting signal in wild-type neprilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "optimized for the overall neuronal clearance of A."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0282416:Overall [Intellectual Product]
   744   C0449297:Clearance [Qualitative Concept]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C1382187:Clearance [Clinical Attribute]
   744   C1561607:Overall [Qualitative Concept]
   744   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Accumulation of amyloid peptide (A)1 in the brain is a triggering event leading to the pathological cascade of Alzheimer's disease (AD) (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Accumulation of amyloid peptide"

Phrase: "(A)1 in the brain"

Phrase: "is"

Phrase: "a triggering event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "leading to the pathological cascade of Alzheimer's disease"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0030664:Pathological [Biomedical Occupation or Discipline]
   744   C0332152:Leading [Temporal Concept]
   744   C1521733:Pathological [Functional Concept]
   744   C1522538:Leading [Functional Concept]
   744   C1707310:Cascade [Manufactured Object]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(AD) (1"

Phrase: ")."
Processing 00000000.tx.13: A is a physiological peptide, the steady-state level of which is strictly determined through a balance between the anabolic and catabolic activities. 

Phrase: "A"

Phrase: "is"

Phrase: "a physiological peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "the steady-state level of which"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0678587:steady state [Natural Phenomenon or Process]
   790   C0683927:state level [Spatial Concept]
   753   C0205361:Steady [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
   753   C3148680:State [Geographic Area]

Phrase: "is"

Phrase: "strictly"

Phrase: "determined through a balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]

Phrase: "between the anabolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002744:Anabolic [Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "catabolic activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.14: Changes in the metabolic balance are closely associated with A accumulation, because an increase in A anabolic activity causes A deposition in almost all cases of familial AD (2, 3). 

Phrase: "Changes in the metabolic balance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "closely"

Phrase: "associated with A accumulation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "because"

Phrase: "an increase in A anabolic activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "A deposition in almost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]

Phrase: "all cases of familial AD (2,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: In sporadic AD brains, where elevation of anabolism seems to be rare, a reduction in catabolic activity involving A-degrading enzyme(s) has been a candidate cause that may account for A accumulation. 

Phrase: "In sporadic AD brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "where elevation of anabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439775:Elevation [Therapeutic or Preventive Procedure]
   770   C0702240:Elevation [Spatial Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "rare,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "a reduction in catabolic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "A-degrading enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "("

Phrase: "s)"

Phrase: "has"

Phrase: "been"

Phrase: "a candidate"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "account for A accumulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
Processing 00000000.tx.16: Recently, several proteases, such as neprilysin (4), insulin-degrading enzyme (5, 6), and endothelin-converting enzymes 1 and 2 (7), have been identified as A-degrading enzymes in the brain by reverse genetic studies. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "several proteases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "such as neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "endothelin-converting enzymes 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   983   C0246118:Endothelin-converting enzyme 1 [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1414244:ENDOTHELIN-CONVERTING ENZYME 1 [Gene or Genome]
   902   C0079281:Endothelin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1414260:ENDOTHELIN 1 [Gene or Genome]
   890   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]
   812   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "been"

Phrase: "identified as A-degrading enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "by reverse genetic studies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C2827447:Genetic Study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
Processing 00000000.tx.17: Deficiencies of these proteases were associated with an elevation of brain A levels in each case, demonstrating that a reduction in the catabolic activity will also contribute to AD development by promoting A accumulation. 

Phrase: "Deficiencies of these proteases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   859   C1281611:Deficiency of protease [Disease or Syndrome]
   737   C0011155:Deficiency [Functional Concept]
   737   C0162429:Deficiency [Disease or Syndrome]
   737   C1623416:deficiency [Qualitative Concept]

Phrase: "were"

Phrase: "associated with an elevation of brain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "A levels in each case,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "a reduction in the catabolic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2267000:Reduction Activity [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "will"

Phrase: "also"

Phrase: "contribute to AD development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: "by promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "A accumulation."
Processing 00000000.tx.18: Although these peptidases are likely to contribute to overall A clearance in the brain by complementing each other in a subcellular, cell type- and/or brain region-specific manner, neprilysin seems to play the primary role among all the A-degrading enzymes thus far examined (8, 9). 

Phrase: "Although"

Phrase: "these peptidases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0030940:Peptidases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1947941:Peptidase [Enzyme]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to overall"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0282416:Overall [Intellectual Product]
   861   C1561607:Overall [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]

Phrase: "A clearance in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "by complementing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "each other in a subcellular, cell type-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0007634:Cell Type [Cell]
           Cell
   778   C0449475:cell type [Intellectual Product]
   748   C0332307:Type [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1547052:*Type [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "and/or"

Phrase: "brain region-specific manner,"

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "the primary role among all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the A-degrading enzymes thus far"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0014442:Enzymes [Enzyme,Organic Chemical]
   804   C0014445:enzymes [Functional Concept]
   804   C0205108:far [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.19: It is also important that the in vivo action of neprilysin in the brain is quite selective for A; 

Phrase: "It"

Phrase: "is"

Phrase: "also important"

Phrase: "that"

Phrase: "the in vivo action of neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "quite selective for A"

Phrase: ";"
Processing 00000000.tx.20: neprilysin deficiency does not elevate the levels of such "neprilysin substrate" neuropeptides as enkephalin (10), cholecystokinin, neuropeptide Y, and substance P,2 indicating the presence of redundant buffering mechanisms to metabolize these peptides. 

Phrase: "neprilysin deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "the levels of such ""neprilysin substrate"" neuropeptides"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "as enkephalin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014298:Enkephalin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "cholecystokinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008328:Cholecystokinin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1413167:CHOLECYSTOKININ [Gene or Genome]

Phrase: "neuropeptide Y,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "substance P,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038585:Substance P [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1420563:substance P [Gene or Genome]
   861   C0439861:Substance [Substance]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "indicating"

Phrase: "the presence of redundant buffering mechanisms to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "metabolize"

Phrase: "these peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.21: Moreover, brain neprilysin expression was selectively reduced not only in aged rodents (11) but also in the early stages of sporadic AD cases (12, 13), suggesting that up-regulation of neprilysin in the brain may prevent AD development by increasing A clearance. 

Phrase: "Moreover,"

Phrase: "brain neprilysin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "selectively"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "not only in aged rodents"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0001779:Aged [Organism Attribute]
   760   C0001792:Aged [Population Group]
   760   C0035804:Rodents [Mammal]
   760   C0205171:Only [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1720467:Only [Intellectual Product]
   760   C1999167:aged [Population Group]

Phrase: "(11"

Phrase: ")"

Phrase: "but"

Phrase: "also in the early stages of sporadic AD cases"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   764   C2363430:early stages [Temporal Concept]
   748 E C1517886:Early Stage [Classification]
   742   C0205422:Sporadic [Temporal Concept]
   742   C0868928:Cases [Functional Concept]
   742   C1279919:Early [Temporal Concept]
   742   C1306673:Stages [Qualitative Concept]
   742   C1533148:Cases [Quantitative Concept]
   708 E C0205390:Stage [Temporal Concept]
   708 E C1300072:Stage [Clinical Attribute]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "(12,"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that up-regulation of neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "AD development by increasing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "A clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.22: Neprilysin is a type II membrane protein with a catalytic site on the extracytoplasmic side and emerges on the cell surface through the secretory pathway. 

Phrase: "Neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "is"

Phrase: "a type II membrane protein with a catalytic site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0025255:Membrane [Tissue]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]

Phrase: "on the extracytoplasmic side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "and"

Phrase: "emerges on the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "through the secretory pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretory Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.23: A is generated in several organelles, including endoplasmic reticulum (ER), trans-Golgi network (TGN), and endosome (14, 15). 

Phrase: "A"

Phrase: "is"

Phrase: "generated in several organelles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0029219:Organelles [Cell Component]
   770   C3146294:Generated [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "endoplasmic reticulum (ER),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "trans-Golgi network (TGN),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "and"

Phrase: "endosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosome [Cell Component]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.24: Recent evidence indicates that lipid rafts, in which neprilysin is detectable (16, 17), could be involved in A generation (18, 19). 

Phrase: "Recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that lipid rafts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167250:lipid rafts [Cell Component]
   827   C0336849:Raft [Manufactured Object]

Phrase: "in which neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "is"

Phrase: "detectable"

Phrase: "(16,"

Phrase: "17"

Phrase: ")"

Phrase: ","

Phrase: "could"

Phrase: "be"

Phrase: "involved in A generation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079411:Generation [Temporal Concept]
   770   C1314939:Involved [Functional Concept]
   770   C3146294:Generation [Activity]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.25: We showed that not only extracellular but also cell-associated A levels were reduced by overexpression of neprilysin in primary cortical neurons using Sindbis viral vector (20), suggesting that neprilysin may degrade A through a secretory pathway and possibly on the cell surface. 

Phrase: "We"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "not only extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521119:Extracellular [Cell Component]

Phrase: "but"

Phrase: "also cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "reduced by overexpression of neprilysin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1366499:NEPRILYSIN [Gene or Genome]
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in primary cortical neurons"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   827   C0001613:Cortical [Body Part, Organ, or Organ Component]
   827   C0007776:Cortical [Body Part, Organ, or Organ Component]
   827   C0022655:Cortical [Body Part, Organ, or Organ Component]
   827   C0027882:Neurons [Cell]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   771 E C0234875:bark [Organism Attribute]
   771 E C2700441:Bark [Plant]
   743 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   743 E C0521390:Neuronal [Immunologic Factor]
   743 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sindbis viral vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1520007:Viral Vector [Pharmacologic Substance]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "may"

Phrase: "degrade"

Phrase: "A through a secretory pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1159342:Secretory Pathway [Cell Function]
   760   C1327616:Secretory [Cell Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "possibly on the cell surface."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2362652:Possibly [Qualitative Concept]
Processing 00000000.tx.26: In this study, we constructed several neprilysin chimeric proteins for targeting to particular organelles, such as ER, TGN, and early/recycling endosomes, and lipid raft fractions, and we investigated the sites of neuronal subcellular compartments that might be closely associated with A metabolism. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "several neprilysin chimeric proteins for targeting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   767   C1159372:Protein Targeting [Molecular Function]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to particular organelles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]

Phrase: "such as ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "TGN,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "and"

Phrase: "early/recycling endosomes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0887883:Early endosome [Cell Component]
   867   C2262706:recycling endosome [Cell Component]
   827   C0034850:Endosomes [Cell Component]
   827   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "lipid raft fractions,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C1167250:lipid raft [Cell Component]

Phrase: "and"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the sites of neuronal subcellular compartments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "might"

Phrase: "be"

Phrase: "closely"

Phrase: "associated with A metabolism."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.27: For this purpose, we used well characterized organelle-targeting domains derived from type II transmembrane proteins or a transmembrane-associated protein, which show the same orientation of peptide sequence on the membrane as neprilysin. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "well characterized organelle-targeting domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]

Phrase: "derived from type II transmembrane proteins"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0441730:Type II [Classification]
   756   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C1167322:transmembrane [Cell Component]
   753   C1441547:Derived [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C2752508:transmembrane [Cell Component]
   753   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "a transmembrane-associated protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the same orientation of peptide sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0029266:Orientation [Mental Process]
   753   C1704322:orientation [Spatial Concept]
   753   C1704972:Orientation [Spatial Concept]
   753   C3539923:Orientation [Intellectual Product]

Phrase: "on the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "as neprilysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.28: We replaced the transmembrane domain of neprilysin with that of Sec12p, which is essential for retention in ER (21). 

Phrase: "We"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "the transmembrane domain of neprilysin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1519623:Transmembrane Domain [Amino Acid Sequence]
   760   C1167322:transmembrane [Cell Component]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C2752508:transmembrane [Cell Component]
   760   C3541951:Domain [Intellectual Product]

Phrase: "with that"

Phrase: "of Sec12p,"

Phrase: "which"

Phrase: "is"

Phrase: "essential for retention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205224:Essential [Qualitative Concept]

Phrase: "in ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.29: For TGN and endosome targeting, we fused the extracellular domain of neprilysin to the intracellular and transmembrane regions derived from -galactoside 2,6-sialyltransferase (ST) or transferrin receptor (TfR), which contains the TGN (22) or early/recycling endosomes (23) retention motif, respectively. 

Phrase: "For TGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "and"

Phrase: "endosome targeting,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521840:Targeting [Functional Concept]
   827 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "we"

Phrase: "fused"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0699952:Fused [Functional Concept]
   966 E C1414861:FUSE [Gene or Genome]
   966 E C1708111:Fuse [Manufactured Object]

Phrase: "the extracellular domain of neprilysin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1517050:Extracellular Domain [Spatial Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "to the intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "and"

Phrase: "transmembrane regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   966   C1519623:Transmembrane Region [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "derived from -galactoside 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016956:galactoside [Carbohydrate]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "6-sialyltransferase (ST)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037039:sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0163611:Sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "transferrin receptor (TfR),"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
  1000   C1619635:Transferrin Receptor [Immunologic Factor]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the TGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "(22"

Phrase: ")"

Phrase: "or"

Phrase: "early/recycling endosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0887883:Early endosome [Cell Component]
   867   C2262706:recycling endosome [Cell Component]
   827   C0034850:Endosomes [Cell Component]
   827   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "retention motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "respectively."
Processing 00000000.tx.30: Finally, the N-terminal domain of growth-associated protein 43 (GAP43) (24) was fused to the N terminus of neprilysin for delivery to the lipid raft fraction. 

Phrase: "Finally,"

Phrase: "the N-terminal domain of growth-associated protein 43 (GAP43)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0162808:Protein Domain [Spatial Concept]
   762   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "(24"

Phrase: ")"

Phrase: "was"

Phrase: "fused to the N terminus of neprilysin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0699952:Fused [Functional Concept]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]

Phrase: "for delivery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011209:Delivery [Therapeutic or Preventive Procedure]
  1000   C0559563:delivery [Finding]
  1000   C1705822:Delivery [Activity]

Phrase: "to the lipid raft fraction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C1167250:lipid raft [Cell Component]
Processing 00000000.tx.31: In addition to these neprilysin chimeric proteins, we expressed wild-type and inactive mutant neprilysin as positive and negative controls, respectively, in primary cortical neurons by use of the Semliki Forest virus (SFV) gene expression system, and we examined their effects on A clearance.  

Phrase: "In addition to these neprilysin chimeric proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "expressed"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "inactive mutant neprilysin as positive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "respectively,"

Phrase: "in primary cortical neurons"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   827   C0001613:Cortical [Body Part, Organ, or Organ Component]
   827   C0007776:Cortical [Body Part, Organ, or Organ Component]
   827   C0022655:Cortical [Body Part, Organ, or Organ Component]
   827   C0027882:Neurons [Cell]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   771 E C0234875:bark [Organism Attribute]
   771 E C2700441:Bark [Plant]
   743 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   743 E C0521390:Neuronal [Immunologic Factor]
   743 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of the Semliki Forest virus (SFV) gene expression system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "their effects on A clearance."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.32: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  AntibodiesMouse monoclonal (56C6) and rabbit polyclonal (H-321) antibodies to the extracellular domain of human neprilysin were purchased from Novocastra Laboratories (Newcastle, UK) and Santa Cruz Biotechnology Inc. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "AntibodiesMouse"

Phrase: "monoclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]

Phrase: "(56C6"

Phrase: ")"

Phrase: "and"

Phrase: "rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "polyclonal"

Phrase: "(H-321"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "antibodies to the extracellular domain of human neprilysin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Novocastra Laboratories"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0869011:purchased [Activity]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "(Newcastle,"

Phrase: "UK"

Phrase: ")"

Phrase: "and"

Phrase: "Santa Cruz Biotechnology Inc."
Processing 00000000.tx.33: (Santa Cruz, CA), respectively. 

Phrase: "(Santa Cruz,"

Phrase: "CA),"

Phrase: "respectively."
Processing 00000000.tx.34: Anti-immunoglobulin heavy chain-binding protein (BiP) and anti-adaptin mouse monoclonal antibodies were from BD Transduction Laboratories (Lexington, KY); 

Phrase: "Anti-immunoglobulin heavy chain-binding protein (BiP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   947   C0063423:immunoglobulin heavy chain-binding protein [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1415761:IMMUNOGLOBULIN HEAVY CHAIN-BINDING PROTEIN [Gene or Genome]
   885   C1412030:Immunoglobulin Binding Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1149306:immunoglobulin binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "anti-adaptin mouse monoclonal antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   897   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   881 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   867   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   840   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0746619:monoclonal [Finding]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from BD Transduction Laboratories"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C1160185:transduction [Organism Function]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "(Lexington,"

Phrase: "KY"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.35: anti-syntaxin 13 mouse monoclonal antibody was from StressGen Biotechnologies Corp. 

Phrase: "anti-syntaxin 13 mouse monoclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0746619:monoclonal [Finding]

Phrase: "was from StressGen Biotechnologies Corp."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0005574:Biotechnologies [Biomedical Occupation or Discipline]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0683758:Corp. [Organization]
   760   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.36: (British Columbia, Canada), and fluorochrome-conjugated secondary antibodies were from Molecular Probes (Eugene, OR). 

Phrase: "(British Columbia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0006193:British Columbia [Geographic Area]
   861   C1551442:Columbia [Population Group]
   861   C3245499:Columbia [Health Care Related Organization]
   789 E C1551955:Columbian [Language]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "fluorochrome-conjugated secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Molecular Probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   770   C0182400:Probes [Medical Device]
   770   C1521991:Molecular [Qualitative Concept]
   737 E C1704681:Probe [Gene or Genome]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C3536729:Probe [Manufactured Object]

Phrase: "(Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.37: Rabbit anti-rat microtubule-associated protein-2 (MAP-2) antiserum was described previously (25). 

Phrase: "Rabbit anti-rat microtubule-associated protein-2 (MAP-2) antiserum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   723   C1455604:microtubule-associated protein 2, rat [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.38: Construction of Recombinant SFV Vectors and InfectionHuman wild-type and inactive mutant neprilysin cDNAs in pBluescript II KS (+) were prepared as described previously (20, 26, 27). 

Phrase: "Construction of Recombinant SFV Vectors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "InfectionHuman"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "inactive mutant neprilysin cDNAs in pBluescript II KS (+)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20,"

Phrase: "26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.39: The cDNAs encoding neprilysin chimeric proteins for targeting of neprilysin enzyme activity to a particular organelle or lipid raft fraction, Sec12-neprilysin (NEP) to ER, ST-NEP to TGN, TfR-NEP to early/recycling endosomes, and GAP43-NEP to lipid raft fraction were constructed as follows. 

Phrase: "The cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "neprilysin chimeric proteins for targeting of neprilysin enzyme activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   745   C1159372:Protein Targeting [Molecular Function]
   745   C1537044:protein activity [Molecular Function]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to a particular organelle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelle [Cell Component]

Phrase: "or"

Phrase: "lipid raft fraction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C1167250:lipid raft [Cell Component]

Phrase: "Sec12-neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: ")"

Phrase: "to ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "ST-NEP to TGN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "TfR-NEP to early/recycling endosomes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "GAP43-NEP to lipid raft fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.40: Neprilysin cytoplasmic domain fragment encoding amino acid residues 127 (NEP/CD127) was amplified by PCR using two oligonucleotide primers (5'-GGAAGCTTTAGGTGATGGGCAAGTCAGAAAGT-3' and 5'-GGGGCGCCCAGTGGAGTCCATCGCTGTTTCTT-3'), and then digested with HindIII and NarI. 

Phrase: "Neprilysin cytoplasmic domain fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acid residues 127"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(NEP/CD127"

Phrase: ")"

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "(5'-GGAAGCTTTAGGTGATGGGCAAGTCAGAAAGT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GGGGCGCCCAGTGGAGTCCATCGCTGTTTCTT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "digested with HindIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "NarI."
Processing 00000000.tx.41: Yeast Sec12p transmembrane domain fragment (Sec12/TMD) encoding amino acid residues 355373 was made by annealing synthetic oligonucleotides (5'-CGCCTTTTTCACCAACTTCATCCTTATTGTGCTGCTTTCTTACATTTTACAGTTCTCCTAT-3' and 5'-ATAGGAGAACTGTAAAATGTAAGAAAGCAGCACAATAAGGATGAAGTTGGTGAAAAAGG-3'). 

Phrase: "Yeast Sec12p transmembrane domain fragment (Sec12/TMD)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acid residues 355373"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "made by annealing synthetic oligonucleotides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1883254:synthetic [Activity]
   726   C1881534:Make [Functional Concept]

Phrase: "(5'-CGCCTTTTTCACCAACTTCATCCTTATTGTGCTGCTTTCTTACATTTTACAGTTCTCCTAT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-ATAGGAGAACTGTAAAATGTAAGAAAGCAGCACAATAAGGATGAAGTTGGTGAAAAAGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.42: Neprilysin extracellular domain encoding amino acid residues 55750 (NEP/ECD55750) was constructed by ligation of a PCR product using two oligonucleotide primers (5'-GGCCCGGGATTTGCAAGTCATCAGACTGC-3' and 5'-TCCAGTGCATTCATAGTAATCTCT-3') and an XbaI-digested fragment of neprilysin cDNA in pBluescript II, and then digested with HindIII and SmaI. 

Phrase: "Neprilysin extracellular domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1517050:Extracellular Domain [Spatial Concept]
   827   C0521119:Extracellular [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acid residues 55750"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(NEP/ECD55750"

Phrase: ")"

Phrase: "was"

Phrase: "constructed by ligation of a PCR product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0023690:Ligation [Therapeutic or Preventive Procedure]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]
   714   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "(5'-GGCCCGGGATTTGCAAGTCATCAGACTGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-TCCAGTGCATTCATAGTAATCTCT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "an XbaI-digested fragment of neprilysin cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "in pBluescript II,"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "digested with HindIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "SmaI."
Processing 00000000.tx.43: Finally, three DNA fragments, NEP/CD127, Sec12/TMD, and NEP/ECD55750, were ligated, resulting in Sec12-NEP. 

Phrase: "Finally,"

Phrase: "three DNA fragments,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "NEP/CD127,"

Phrase: "Sec12/TMD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "NEP/ECD55750,"

Phrase: "were"

Phrase: "ligated"

Phrase: ","

Phrase: "resulting in Sec12-NEP."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332294:Resulting in [Functional Concept]
   770   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0678226:resulting [Functional Concept]
   770   C1366499:NEPRILYSIN [Gene or Genome]
   770   C1418883:SEC12 [Gene or Genome]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]
Processing 00000000.tx.44: For ST-NEP construction, rat ST cytoplasmic domain encoding residues 138 (ST/CD138) was amplified by PCR using primers (5'-GGAAGCTTTCCTGTCTGGACCATTCATTATGA-3' and 5'-GGCAGCTGCAGTGTAAGGGCCTCATAGTC-3') and rat ST cDNA as a template, digested with HindIII and PvuII, and ligated with NEP/ECD55750. 

Phrase: "For ST-NEP construction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "rat ST cytoplasmic domain encoding residues 138"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   818   C1511625:Cytoplasmic Domain [Cell Component]
   795   C0010834:Cytoplasmic [Cell Component]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C0037039:sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0163611:Sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0521449:Cytoplasmic [Body Location or Region]
   795   C1547699:Encoding [Idea or Concept]
   795   C1880389:Domain [Functional Concept]
   795   C1883221:Domain [Conceptual Entity]
   795   C2700640:Encoding [Activity]
   795   C3541951:Domain [Intellectual Product]
   762   C1709915:Residue [Conceptual Entity]
   762   C1882936:RESIDUE [Phenomenon or Process]
   712 E C1609982:Residual [Qualitative Concept]

Phrase: "(ST/CD138"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3273112:CD138 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-GGAAGCTTTCCTGTCTGGACCATTCATTATGA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GGCAGCTGCAGTGTAAGGGCCTCATAGTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "rat ST cDNA as a template,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "digested with HindIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "PvuII,"

Phrase: "and"

Phrase: "ligated with NEP/ECD55750."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.45: For TfR-NEP construction, human TfR cytoplasmic domain encoding residues 194 (TfR/CD194) was amplified by PCR using primers (5'-GGAAGCTTCTGTGTGGCAGTTCAGAATGATGG-3' and 5'-GGCCCGGGTTCTACCCCTTTACAATAGCC-3') and human liver cDNA library as a template, digested with HindIII and SmaI, and ligated with NEP/ECD55750. 

Phrase: "For TfR-NEP construction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "human TfR cytoplasmic domain encoding residues 194"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   812   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   812   C1511625:Cytoplasmic Domain [Cell Component]
   812   C1619635:Transferrin Receptor [Immunologic Factor]
   793   C0010834:Cytoplasmic [Cell Component]
   793   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0086418:Human [Human]
   793   C0521449:Cytoplasmic [Body Location or Region]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C1442762:TRANSFERRIN [Gene or Genome]
   793   C1547699:Encoding [Idea or Concept]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C2700640:Encoding [Activity]
   793   C3541951:Domain [Intellectual Product]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   710 E C1609982:Residual [Qualitative Concept]
   710 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(TfR/CD194"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1413190:CD194 [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: ")"

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-GGAAGCTTCTGTGTGGCAGTTCAGAATGATGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GGCCCGGGTTCTACCCCTTTACAATAGCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "human liver cDNA library as a template,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "digested with HindIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "SmaI,"

Phrase: "and"

Phrase: "ligated with NEP/ECD55750."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.46: For GAP43-NEP construction, human GAP43 N-terminal domain encoding residues 120 was fused to the N terminus of neprilysin by ligation of a EcoRV-digested fragment of neprilysin cDNA in pBluescript II and two pairs of oligonucleotides (5'-AGGGACGAGACAACCATGCTGTGCTGTATGAGAAGAACCAAACAGGTTGAAAAAAATGAT-3'/5'-TTCAACCTGTTTGGTTCTTCTCATACAGCACAGCATGGTTGTCTCGTCCCT-3' and 5'-GACGACCAAAAGATTATGGGCAAGTCAGAAAGTCAGATGGATATAACTGAT-3'/5'-ATCAGTTATATCCATCTGACTTTCTGACTTGCCCATAATCTTTTGGTCGTCATCATTTTT-3'). 

Phrase: "For GAP43-NEP construction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0441513:Construction [Therapeutic or Preventive Procedure]
   734   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "human GAP43 N-terminal domain encoding residues 120"
Meta Candidates (Total=25; Excluded=3; Pruned=0; Remaining=22)
   832   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   832   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   830   C0162808:Protein Domain [Spatial Concept]
   830   C1514562:Protein Domain [Amino Acid Sequence]
   820   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0018270:'growth' NOS [Organism Function]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0086418:Human [Human]
   788   C0205088:Terminal [Temporal Concept]
   788   C0220844:growth [Physiologic Function]
   788   C0332281:Associated [Qualitative Concept]
   788   C1547699:Encoding [Idea or Concept]
   788   C1621966:Growth [Organ or Tissue Function]
   788   C1705314:Terminal [Manufactured Object]
   788   C1705315:Terminal [Spatial Concept]
   788   C1880389:Domain [Functional Concept]
   788   C1883221:Domain [Conceptual Entity]
   788   C2700640:Encoding [Activity]
   788   C2911660:Growth [Activity]
   788   C3541951:Domain [Intellectual Product]
   755 E C0750490:Associate [Idea or Concept]
   755 E C1706221:Associate [Professional or Occupational Group]
   755   C1709915:Residue [Conceptual Entity]
   755   C1882936:RESIDUE [Phenomenon or Process]
   705 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "fused to the N terminus of neprilysin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0699952:Fused [Functional Concept]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]

Phrase: "by ligation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023690:Ligation [Therapeutic or Preventive Procedure]

Phrase: "of a EcoRV-digested fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "of neprilysin cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in pBluescript II"

Phrase: "and"

Phrase: "two pairs of oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709450:Pair [Qualitative Concept]

Phrase: "(5'-AGGGACGAGACAACCATGCTGTGCTGTATGAGAAGAACCAAACAGGTTGAAAAAAATGAT-3'/5'-TTCAACCTGTTTGGTTCTTCTCATACAGCACAGCATGGTTGTCTCGTCCCT-3'"

Phrase: "and"

Phrase: "5'-GACGACCAAAAGATTATGGGCAAGTCAGAAAGTCAGATGGATATAACTGAT-3'/5'-ATCAGTTATATCCATCTGACTTTCTGACTTGCCCATAATCTTTTGGTCGTCATCATTTTT-3'"

Phrase: ")."
Processing 00000000.tx.47: All cDNA constructs were verified by DNA sequencing and inserted into a pSFV1 vector (Invitrogen). 

Phrase: "All cDNA constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "verified by DNA sequencing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   770   C1711411:Verified [Functional Concept]

Phrase: "and"

Phrase: "inserted into a pSFV1 vector"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0441587:Inserted [Health Care Activity]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.48: To prepare a recombinant viral vector, each cRNA was transcribed from the SapI-linearized DNAs with SP6 RNA polymerase and then cotransfected together with pSFV-Helper1 RNA into baby hamster kidney cells using the Gene Pulser electroporation system (Bio-Rad) according to the manufacturer's instructions. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "a recombinant viral vector,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1520007:Viral Vector [Pharmacologic Substance]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "each cRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056208:cRNA [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1321571:CRNA [Professional or Occupational Group]

Phrase: "was"

Phrase: "transcribed from the SapI-linearized DNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with SP6 RNA polymerase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0140662:SP6 RNA polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0035681:RNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2984241:RNA polymerase [Functional Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cotransfected together with pSFV-Helper1 RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1883357:Together [Qualitative Concept]

Phrase: "into baby hamster kidney cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Gene Pulser electroporation system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Bio-Rad) according to the manufacturer's instructions."
Processing 00000000.tx.49: The conditioned medium containing the recombinant viral vectors was collected at 24 h after transfection and stored at 80 C until use. 

Phrase: "The conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the recombinant viral vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C1520007:Viral Vector [Pharmacologic Substance]
   827   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vectors [Spatial Concept]
   793 E C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "collected at 24 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "stored at 80 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: Primary cortical neurons were prepared from embryonic C57BL/6CrSlc mice as described previously (20). 

Phrase: "Primary cortical neurons"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   827   C0001613:Cortical [Body Part, Organ, or Organ Component]
   827   C0007776:Cortical [Body Part, Organ, or Organ Component]
   827   C0022655:Cortical [Body Part, Organ, or Organ Component]
   827   C0027882:Neurons [Cell]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   771 E C0234875:bark [Organism Attribute]
   771 E C2700441:Bark [Plant]
   743 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   743 E C0521390:Neuronal [Immunologic Factor]
   743 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "prepared from embryonic C57BL/6CrSlc mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0025921:Mice, C57BL [Mammal]
           C57BL
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   719   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.51: Infection was carried out by adding the viral vector solution to culture medium of cortical neurons (34 x 107 cells), which had been cultured for 79 days. 

Phrase: "Infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by adding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   756   C1883712:Add [Functional Concept]

Phrase: "the viral vector solution to culture medium of cortical neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0037633:Solution [Substance]
   739   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(34 x 107 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "had"

Phrase: "been"

Phrase: "cultured for 79 days."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0439228:days [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439505:/day [Temporal Concept]
   737   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.52: At 16 h after the infection, the conditioned medium and the cell lysate were subjected to assay. 

Phrase: "At 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after the infection,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "the conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "the cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.53: When neurons were moved from in vivo conditions to in vitro conditions, the expression level of neprilysin declined for unknown reasons. 

Phrase: "When"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "moved from in vivo conditions"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C1269909:Moved from [Functional Concept]
           moved
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C1299988:moved [Functional Concept]
   760   C2699029:Moved [Activity]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0560560:move [Organism Function]
   726 E C0578671:move [Finding]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "to in vitro conditions,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the expression level of neprilysin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "declined for unknown reasons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392360:reasons [Idea or Concept]
   770   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.54: Western Blot Analysis and Assay for Neutral Endopeptidase Activity Infected neurons were extensively washed with PBS, collected, and lysed with 1% Triton X-100 lysis buffer. 

Phrase: "Western Blot Analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "Assay for Neutral Endopeptidase Activity Infected neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "extensively"

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "lysed with 1% Triton X-100 lysis buffer."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0024348:Lysis [Pathologic Function]
           lysed
   744   C0242759:Triton [Geographic Area]
   744   C1536403:lysis [Cell Function]
Processing 00000000.tx.55: Aliquots of the cell lysates were subjected to Western blot analysis using 56C6 and to assay for neutral endopeptidase activity using benzyloxycarbonyl-alanyl-alanyl-leucine-p-nitroanilide (Peptide Institute, Osaka, Japan) as a substrate, as described previously (26, 28). 

Phrase: "Aliquots of the cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "56C6"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay for neutral endopeptidase activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0025250:Neutral Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1150171:endopeptidase activity [Molecular Function]
   806   C1366499:neutral endopeptidase [Gene or Genome]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0243073:assay [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1510438:Assay [Laboratory Procedure]
   760   C1561536:*Activity [Idea or Concept]
   760   C1882074:Neutral [Qualitative Concept]
   760   C2825492:Neutral [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "benzyloxycarbonyl-alanyl-alanyl-leucine-p-nitroanilide"

Phrase: "(Peptide Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Osaka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "as a substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(26,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.56: Neprilysin-dependent neutral endopeptidase activity was evaluated from the decrease in the rate of digestion caused by 10 M thiorphan, a specific inhibitor of neprilysin. 

Phrase: "Neprilysin-dependent neutral endopeptidase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C1150197:neprilysin activity [Molecular Function]
   840   C1150171:endopeptidase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "evaluated from the decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220825:Evaluated [Functional Concept]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "caused by 10 M thiorphan,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "a specific inhibitor of neprilysin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.57: Protein concentrations were determined using a BCA protein assay kit (Pierce). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a BCA protein assay kit (Pierce"

Phrase: ")."
Processing 00000000.tx.58: For Western blot-based quantitative analysis, the intensities of immunoreactive bands were measured with a densitometer, LAS-3000 and Science Lab 2001 Image Gauge software (Fuji Photo Film, Tokyo, Japan). 

Phrase: "For Western blot-based quantitative analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C0949466:Western blot analysis [Laboratory Procedure]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0392762:Quantitative [Quantitative Concept]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "the intensities of immunoreactive bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:intensities [Qualitative Concept]

Phrase: "were"

Phrase: "measured with a densitometer,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0180321:Densitometer [Medical Device]
   770   C0444706:Measured [Qualitative Concept]
   770   C1706216:Densitometer [Medical Device]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "LAS-3000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1424272:LAS [Gene or Genome]
   861   C1562368:LAS [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Science Lab 2001 Image Gauge software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Fuji Photo Film,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086296:Film [Manufactured Object]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.59: Immunofluorescence AnalysisPrimary neurons cultured on coverslips were infected with recombinant viral vectors and processed for double immunofluorescence staining after the cells had been treated with PBS containing 0.2% Triton X-100 as described previously (20), using the following sets of primary antibodies and appropriate fluorochrome-conjugated secondary antibodies as follows: 56C6/anti-rat MAP-2 antibody and Alexa 568-conjugated goat anti-mouse IgG/Alexa 488-conjugated goat anti-rabbit IgG, anti-BiP antibody/H-321, anti-adaptin antibody/H-321 or anti-syntaxin 13 antibody/H-321, and Alexa 488-conjugated goat anti-mouse IgG/Alexa 568-conjugated goat anti-rabbit IgG. 

Phrase: "Immunofluorescence AnalysisPrimary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "cultured on coverslips"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "infected with recombinant viral vectors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1520007:Viral Vector [Pharmacologic Substance]
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0439663:Infected [Functional Concept]
   760   C0442335:Vectors [Spatial Concept]
   760   C0521026:Viral [Functional Concept]
   760   C1514798:recombinant [Organism]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "processed for double immunofluorescence staining"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0016318:Immunofluorescence [Laboratory Procedure]
   760   C0079603:Immunofluorescence [Laboratory Procedure]
   760   C0205173:Double [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1522240:Processed [Phenomenon or Process]
   760   C1704680:Staining [Finding]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]
   704 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "after the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "been"

Phrase: "treated with PBS"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.2% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following sets of primary antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "appropriate fluorochrome-conjugated secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "56C6/anti-rat MAP-2 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   878   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   822   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   723   C1455604:microtubule-associated protein 2, rat [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alexa 568-conjugated goat anti-mouse IgG/Alexa 488-conjugated goat anti-rabbit IgG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0034493:Rabbit [Mammal]

Phrase: "anti-BiP antibody/H-321,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   876   C0221137:Anti H [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0369286:antibody h [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   827   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033727:H+ [Element, Ion, or Isotope]
   799   C0243122:binding [Functional Concept]
   799   C0441932:H+ [Classification]
   799   C0564385:/h [Quantitative Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "anti-adaptin antibody/H-321"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   875   C0221137:Anti H [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0369286:antibody h [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]
   804   C1179085:Adaptin [Cell Component]

Phrase: "or"

Phrase: "anti-syntaxin 13 antibody/H-321,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   876   C0221137:Anti H [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0369286:antibody h [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   827   C0906203:Syntaxin 13 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0033727:H+ [Element, Ion, or Isotope]
   799   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441932:H+ [Classification]
   799   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Alexa 488-conjugated goat anti-mouse IgG/Alexa 568-conjugated goat anti-rabbit IgG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0034493:Rabbit [Mammal]
Processing 00000000.tx.60: The immunofluorescence signals were observed under an IX70 inverted microscope incorporating a confocal laser scanning system FV300 (Olympus Optical, Tokyo, Japan). 

Phrase: "The immunofluorescence signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "observed under an IX70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "inverted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443241:Inverted [Qualitative Concept]

Phrase: "microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181839:Microscope [Medical Device]
  1000   C1706379:Microscope [Medical Device]

Phrase: "incorporating"

Phrase: "a confocal laser scanning system FV300"

Phrase: "(Olympus Optical, Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.61: The digital images were captured with Fluoview, version 3.2 software (Olympus Optical), using a x100 objective. 

Phrase: "The digital images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured with Fluoview,"

Phrase: "version 3.2 software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Olympus"

Phrase: "Optical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0042789:Vision [Organism Function]
   944   C2707266:Vision [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a x100 objective."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018017:Objective [Intellectual Product]
   861   C1571702:Objective [Qualitative Concept]
Processing 00000000.tx.62: Eight-bit gray scale images were saved as digitized tagged image format files to retain maximum resolution. 

Phrase: "Eight-bit gray scale images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C1704254:Image [Intellectual Product]
   771   C1704922:Image [Entity]
   771   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "saved as digitized tagged image format"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C1301627:Format [Intellectual Product]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1704254:Image [Intellectual Product]
   753   C1704922:Image [Entity]
   753   C1708632:Tagged [Qualitative Concept]
   753   C3542466:Image [Intellectual Product]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]
   719   C2347840:Save [Machine Activity]

Phrase: "files"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016094:File [Occupational Activity]
  1000   C0180853:File [Medical Device]
  1000   C1522646:File [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "maximum resolution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514893:Resolution [Idea or Concept]
   861   C1706463:Resolution [Quantitative Concept]
   861   C2699488:Resolution [Conceptual Entity]
Processing 00000000.tx.63: Colocalized areas of immunoreactive neprilysin and each marker protein in neurons were quantitated using image analysis software, MetaMorph, version 6.1 (Nippon Roper, Chiba, Japan). 

Phrase: "Colocalized areas of immunoreactive neprilysin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "and"

Phrase: "each marker protein in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "image analysis software,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
   734   C0200765:Image analysis [Laboratory Procedure]

Phrase: "MetaMorph,"

Phrase: "version 6.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "(Nippon Roper,"

Phrase: "Chiba,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.64: Each set of experiments was repeated at least two times. 

Phrase: "Each"

Phrase: "set of experiments"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated at least"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205341:Repeated [Functional Concept]
   756 E C1547730:Repeat [Temporal Concept]
   756 E C1705914:Repeat [Conceptual Entity]

Phrase: "two times."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1948050:Two Times [Quantitative Concept]
   861   C0040223:times [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.65: Lipid Raft FractionationVirus-infected neurons (1 x 108 cells) were extensively washed with PBS, collected, and homogenized in MES-buffered saline (MBS: 25 mM MES, pH 6.5, 0.15 M NaCl) containing 1% Triton X-100, protease inhibitor mixture (CompleteTM, EDTA-free, Roche Diagnostics), and 0.7 g/ml pepstatin A (Peptide Institute) through a 22-gauge needle (20 passages) on ice, followed by incubation at 4 C for 30 min. 

Phrase: "Lipid Raft FractionationVirus-infected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(1 x 108 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "extensively"

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "homogenized in MES-buffered saline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0265215:MES [Congenital Abnormality]
   760   C1417092:MES [Gene or Genome]

Phrase: "(MBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221060:MBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1417581:MBS [Gene or Genome]

Phrase: ":"

Phrase: "25 mM MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0265215:MES [Congenital Abnormality]
   827   C1417092:MES [Gene or Genome]

Phrase: "pH 6.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.15 M NaCl)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "protease inhibitor mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439962:Mixture [Substance]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "(CompleteTM,"

Phrase: "EDTA-free, Roche Diagnostics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0011900:Diagnostic [Finding]
   779   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.7 g/ml pepstatin A (Peptide Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0021622:institute [Organization]
   793   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "through a 22-gauge needle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027551:Needle [Medical Device]
   827   C1704318:Needle [Medical Device]
   827   C1882041:Needle [Spatial Concept]
   734   C0450404:22 gauge [Quantitative Concept]

Phrase: "(20 passages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439799:Passage [Spatial Concept]

Phrase: ")"

Phrase: "on ice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "at 4 C"

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.66: After centrifugation at 2,000 x g for 10 min, 2 ml of the supernatant was mixed with an equivalent volume of 80% sucrose solution, and overlaid sequentially with 4 ml of 35% sucrose and 4 ml of 5% sucrose. 

Phrase: "After centrifugation at 2,"

Phrase: "000 x g for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0560021:g/min [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]

Phrase: "2 ml of the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "mixed with an equivalent volume of 80% sucrose solution,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   742   C0037633:Solution [Substance]
   742   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0205163:Equivalent [Qualitative Concept]
   742   C0205430:Mixed [Functional Concept]
   742   C0439185:equivalent [Quantitative Concept]
   742   C0449468:*Volume [Quantitative Concept]
   742   C0525069:Solution [Biomedical or Dental Material]
   742   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2700258:Volume [Laboratory Procedure]
   742   C3160715:Mixed [Finding]
   708 E C1421951:MIX [Gene or Genome]
   708 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "overlaid sequentially with 4 ml of 35% sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0444456:Overlay [Spatial Concept]
   711   C1706359:Overlay [Medical Device]

Phrase: "and"

Phrase: "4 ml of 5% sucrose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.67: The gradient was centrifuged at 39,000 rpm for 21 h with an SW41 rotor, and then 12 fractions (1 ml each) were collected from top to bottom. 

Phrase: "The gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "was"

Phrase: "centrifuged at 39,000 rpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0582523:rpm [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 21 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with an SW41 rotor,"

Phrase: "and"

Phrase: "then 12 fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "(1 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "each"

Phrase: ")"

Phrase: "were"

Phrase: "collected from top"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C1704458:Top [Spatial Concept]

Phrase: "to bottom."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]
Processing 00000000.tx.68: The pellet (fraction 13) was resuspended in 1 ml of MBS by sonication. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "(fraction 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "resuspended in 1 ml of MBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0221060:MBS [Congenital Abnormality,Disease or Syndrome]
   753   C0439526:/mL [Quantitative Concept]
   753   C1417581:MBS [Gene or Genome]

Phrase: "by sonication."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037680:Sonication [Research Activity]
Processing 00000000.tx.69: Aliquots of all fractions were subjected to Western blot analysis to evaluate targeting of GAP43-NEP chimeric protein to the lipid raft fraction. 

Phrase: "Aliquots of all fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to Western blot analysis to"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "targeting of GAP43-NEP chimeric protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1159372:Protein Targeting [Molecular Function]
   742   C1521840:Targeting [Functional Concept]
   708 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "to the lipid raft fraction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C1167250:lipid raft [Cell Component]
Processing 00000000.tx.70: Measurement of A Extracellular A in conditioned medium and intracellular A extracted with 6 M guanidine HCl from cultured neurons were measured by sandwich enzyme-linked immunosorbent assay (ELISA) as described previously (20, 29, 30), using BNT77/BA27 and BNT77/BC05 monoclonal antibodies for A40 and A42, respectively.  

Phrase: "Measurement of A Extracellular A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "in conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "intracellular A"

Phrase: "extracted with 6 M guanidine HCl"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0018320:guanidine [Organic Chemical]
   753   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "from cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "measured by sandwich enzyme-linked immunosorbent assay (ELISA)"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   853   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20,"

Phrase: "29,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BNT77/BA27"

Phrase: "and"

Phrase: "BNT77/BC05 monoclonal antibodies for A40"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0746619:monoclonal [Finding]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "A42,"

Phrase: "respectively."
Processing 00000000.tx.71: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Expression of Neprilysin Chimeric Proteins in Primary Cortical NeuronsExpression levels and relative molecular masses of wild-type, inactive mutant neprilysin, and the neprilysin chimeric proteins (Fig. 1) in primary neurons were analyzed by Western blotting at 16 h after the transfection with SFV vector (Fig. 2, A and B). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression of Neprilysin Chimeric Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Primary Cortical NeuronsExpression levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "relative molecular masses of wild-type, inactive mutant neprilysin,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]
   708   C0577559:Mass [Finding]
   708   C1306372:*Mass [Quantitative Concept]

Phrase: "and"

Phrase: "the neprilysin chimeric proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "in primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "at 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after the transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with SFV vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]
   756   C0036636:Semliki forest virus [Virus]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.72: Anti-neprilysin antibody 56C6 used here recognizes the extracellular domain of neprilysin, which is shared by all the constructs. 

Phrase: "Anti-neprilysin antibody 56C6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "recognizes"

Phrase: "the extracellular domain of neprilysin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1517050:Extracellular Domain [Spatial Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "shared by all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237876:shared [Social Behavior]
   790   C1522138:Shared [Functional Concept]

Phrase: "the constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]
Processing 00000000.tx.73: Sec12-NEP showed a molecular mass of 100 kDa, which is similar to that of the wild-type and mutant neprilysin. 

Phrase: "Sec12-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a molecular mass of 100 kDa,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   783   C0577559:A mass [Finding]
           Mass
   753   C1306372:*Mass [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "similar to that of the wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "mutant neprilysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.74: The molecular masses of ST-NEP, TfR-NEP, and GAP43-NEP were slightly altered from that of the wild type in accordance with the changes in the amino acid residues (see Fig. 1). 

Phrase: "The molecular masses of ST-NEP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   719   C0577559:Mass [Finding]
   719   C1306372:*Mass [Quantitative Concept]

Phrase: "TfR-NEP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "and"

Phrase: "GAP43-NEP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366499:NEPRILYSIN [Gene or Genome]
   771   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "were"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "altered from that of the wild type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0392747:Altered [Functional Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "in accordance with the changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in the amino acid residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.75: The mutant, ST-NEP, TfR-NEP, and GAP43-NEP chimeric proteins were expressed at similar levels to the wild-type, but the expression level of Sec12-NEP was 60% lower than those of the others (Fig. 2B). 

Phrase: "The mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "ST-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "TfR-NEP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "and"

Phrase: "GAP43-NEP chimeric proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "were"

Phrase: "expressed at similar levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "to the wild-type,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "but"

Phrase: "the expression level of Sec12-NEP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "60% lower than those of the others"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.76: View larger version (32K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.77: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.78: Schematic diagram of wild-type neprilysin, inactive mutant neprilysin, and neprilysin chimeric proteins. 

Phrase: "Schematic diagram of wild-type neprilysin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681494:Diagram [Intellectual Product]

Phrase: "inactive mutant neprilysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "neprilysin chimeric proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.79: Inactive mutant neprilysin has an amino acid (a.a.) substitution of Glu-585 to Val. 

Phrase: "Inactive mutant neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "has"

Phrase: "an amino acid (a.a.) substitution of Glu-585"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0525038:Amino Acid Substitution [Genetic Function,Molecular Biology Research Technique]
   748   C1555721:Substitution [Idea or Concept]
   748   C1706204:Substitution [Activity]

Phrase: "to Val."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.80: Sec12-NEP, ST-NEP, TfR-NEP, and GAP43-NEP contain ER, TGN, early/recycling endosomes, and lipid raft fraction sorting signals as shown by black boxes, respectively. 

Phrase: "Sec12-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "ST-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "TfR-NEP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "and"

Phrase: "GAP43-NEP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366499:NEPRILYSIN [Gene or Genome]
   771   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "TGN,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "early/recycling endosomes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0887883:Early endosome [Cell Component]
   867   C2262706:recycling endosome [Cell Component]
   827   C0034850:Endosomes [Cell Component]
   827   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "lipid raft fraction sorting signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1710082:Signal [Phenomenon or Process]

Phrase: "as"

Phrase: "shown by black boxes,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0179400:boxes [Manufactured Object]
   770   C0439541:Black [Qualitative Concept]
   770   C1638312:Boxes [Quantitative Concept]
   737 E C1533124:Box [Medical Device]
   737   C1547282:Show [Intellectual Product]

Phrase: "respectively."
Processing 00000000.tx.81: Numbers of amino acids in the white boxes represent those derived from neprilysin. 

Phrase: "Numbers of amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0546742:Acid number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in the white boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "those"

Phrase: "derived from neprilysin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1366499:NEPRILYSIN [Gene or Genome]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]
Processing 00000000.tx.82: TM, transmembrane.  

Phrase: "TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
  1000   C3540468:TM [Gene or Genome]

Phrase: "transmembrane."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167322:transmembrane [Cell Component]
  1000   C2752508:transmembrane [Cell Component]
Processing 00000000.tx.83: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.84: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.85: Expression of neprilysin and neprilysin chimeric proteins in primary cortical neurons infected with SFV vector. 

Phrase: "Expression of neprilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "neprilysin chimeric proteins in primary cortical neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "infected with SFV vector."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0036636:Semliki forest virus [Virus]
   753   C0042776:Virus [Virus]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086312:Forest [Geographic Area]
   753   C0319157:virus [Virus]
   753   C0439663:Infected [Functional Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.86: A, cell lysates (5 g) from cells expressing wild-type neprilysin (wt), inactive mutant neprilysin (mut), Sec12-NEP chimera (Sec12), ST-NEP chimera (ST), TfR-NEP chimera (TfR), and GAP43-NEP chimera (GAP43) were subjected to Western blot analysis with anti-neprilysin antibody 56C6. 

Phrase: "A,"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(5 g) from cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0524983:G Cells [Cell]
   770   C0439267:g% [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(wt), inactive mutant neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(mut"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417504:MUT [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "Sec12-NEP chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]

Phrase: "(Sec12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418883:SEC12 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "ST-NEP chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]

Phrase: "(ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037039:sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0163611:Sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "TfR-NEP chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0008109:Chimera [Organism]
   812   C1262946:Chimaera [Fish]
   812   C1318484:Chimera [Disease or Syndrome]

Phrase: "(TfR"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
  1000   C1619635:Transferrin Receptor [Immunologic Factor]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "GAP43-NEP chimera"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0008109:Chimera [Organism]
   799   C1262946:Chimaera [Fish]
   799   C1318484:Chimera [Disease or Syndrome]
   734   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "(GAP43"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "with anti-neprilysin antibody 56C6."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.87: B, quantitative analysis of expression levels of neprilysin and neprilysin chimeric proteins. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitative analysis of expression levels of neprilysin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "neprilysin chimeric proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.88: Intensities of immunoreactive bands shown in A were quantified as described under "Experimental Procedures." 

Phrase: "Intensities of immunoreactive bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:intensities [Qualitative Concept]

Phrase: "shown in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "were"

Phrase: "quantified"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.89: The linearity of the Western blot data has been confirmed. 

Phrase: "The linearity of the Western blot data"

Phrase: "has"

Phrase: "been"

Phrase: "confirmed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.90: Each column with an error bar represents the mean  S.D. of at least four independent experiments. 

Phrase: "Each column with an error bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  S.D."

Phrase: "of"

Phrase: "at least four independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.91: C, neutral endopeptidase activity in cells expressing neprilysin and neprilysin chimeric proteins in the absence (open columns) and presence (closed columns) of thiorphan. 

Phrase: "C,"

Phrase: "neutral endopeptidase activity in cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150171:endopeptidase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "expressing"

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "neprilysin chimeric proteins in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(open columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(closed columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: "of thiorphan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.92: Each column with an error bar represents the mean  S.D. of at least three independent experiments.  

Phrase: "Each column with an error bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  S.D."

Phrase: "of"

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.93: We next determined the infectious efficiency of each viral vector to primary neurons using double immunofluorescence staining for neprilysin and a neuronal marker, MAP-2. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "determined"

Phrase: "the infectious efficiency of each viral vector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013682:Efficiency [Quantitative Concept]

Phrase: "to primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "double immunofluorescence staining for neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "a neuronal marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "MAP-2."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0024773:Microtubule-Associated Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417006:MICROTUBULE-ASSOCIATED PROTEIN 2 [Gene or Genome]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.94: The efficiencies, defined as the ratio of neprilysin-positive neurons to MAP-2-positive neurons, were 67.8  12.3% for the wild-type, 69.1  11.9% for the mutant, 74.6  14.4% for Sec12-NEP, 54.8  5.4% for ST-NEP, 64.7  19.5% for TfR-NEP, and 62.0  13.2% for GAP43-NEP infectants, indicating that all viral vectors had similar titers. 

Phrase: "The efficiencies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013682:efficiencies [Quantitative Concept]
   916 E C0442799:Efficient [Qualitative Concept]

Phrase: "defined as the ratio of neprilysin-positive neurons"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0027882:Neurons [Cell]
   744   C0439178:% Positive [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1366499:NEPRILYSIN [Gene or Genome]
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C1547037:Ratio [Intellectual Product]
   744   C1704788:Defined [Conceptual Entity]
   744   C2825490:Positive [Qualitative Concept]
   744   C3539106:Defined [Intellectual Product]

Phrase: "to MAP-2-positive neurons,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0027882:Neurons [Cell]
   734   C0024773:Microtubule-Associated Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1417006:MICROTUBULE-ASSOCIATED PROTEIN 2 [Gene or Genome]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "67.8  12.3%"

Phrase: "for the wild-type, 69.1  11.9%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C0441729:Type 1 [Classification]
   827   C1883559:Wild Type [Organism Attribute]
   799   C0332307:Type [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C0450388:69 [Intellectual Product]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "for the mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "74.6  14.4% for Sec12-NEP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   748   C1418883:SEC12 [Gene or Genome]

Phrase: "54.8  5.4% for ST-NEP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1539873:SIALYLTRANSFERASE 8 [Gene or Genome]
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0037039:sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0163611:Sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "64.7  19.5% for TfR-NEP,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   770   C1619635:Transferrin Receptor [Immunologic Factor]
   744   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1366499:NEPRILYSIN [Gene or Genome]
   744   C1442762:TRANSFERRIN [Gene or Genome]

Phrase: "and"

Phrase: "62.0  13.2%"

Phrase: "for GAP43-NEP infectants,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "indicating"

Phrase: "that"

Phrase: "all viral vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1520007:Viral Vector [Pharmacologic Substance]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "had"

Phrase: "similar titers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475208:Titer [Quantitative Concept]
Processing 00000000.tx.95: Therefore, the reduced expression of Sec12-NEP was not caused by inefficient infection. 

Phrase: "Therefore,"

Phrase: "the reduced expression of Sec12-NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "caused by inefficient infection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0009450:Infection, NOS [Disease or Syndrome]
   770   C0231185:Inefficient [Functional Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.96: We speculate that it probably was a consequence of rapid turnover of the expressed protein retained in ER rather than a reduction in transcription or translation, because Sec12-NEP and wild-type neprilysin share identical N-terminal amino acid sequences (see "Discussion" for further speculation). 

Phrase: "We"

Phrase: "speculate"

Phrase: "that"

Phrase: "it probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "was"

Phrase: "a consequence of rapid turnover of the expressed protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "retained in ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   770   C0333118:Retained [Functional Concept]

Phrase: "rather than"

Phrase: "a reduction in transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "translation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]

Phrase: "because"

Phrase: "Sec12-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "identical N-terminal amino acid sequences"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1706793:N-Terminal Amino Acid [Amino Acid Sequence]
   861   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   827   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C2917660:Amino Acid [Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0162326:Sequences [Nucleotide Sequence]
   799   C0202406:Acid [Laboratory Procedure]
   766 E C0004793:Sequence [Nucleotide Sequence]
   766 E C0162327:Sequence [Nucleotide Sequence]
   766 E C1519249:Sequence [Functional Concept]
   716 E C1548958:Sequential [Idea or Concept]
   716 E C1705294:Sequential [Qualitative Concept]

Phrase: "(see ""Discussion"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: "for further speculation"

Phrase: ")."
Processing 00000000.tx.97: Levels of thiorphan-sensitive endoproteolytic activity to hydrolyze benzyloxycarbonyl-alanyl-alanyl-leucine-p-nitroanilide were essentially consistent with the protein expression levels of the wild-type or neprilysin chimeric proteins except for Sec12-NEP (Fig. 2C). 

Phrase: "Levels of thiorphan-sensitive endoproteolytic activity to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   774   C0683317:activity levels [Finding]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "hydrolyze"

Phrase: "benzyloxycarbonyl-alanyl-alanyl-leucine-p-nitroanilide"

Phrase: "were"

Phrase: "essentially consistent with the protein expression levels of the wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "or"

Phrase: "neprilysin chimeric proteins except for Sec12-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.98: ST-NEP, TfR-NEP, and GAP43-NEP infectants showed peptidase activities comparable with that of the wild-type infectants. 

Phrase: "ST-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "TfR-NEP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "and"

Phrase: "GAP43-NEP infectants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "peptidase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150095:peptidase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "comparable with that of the wild-type infectants."
Processing 00000000.tx.99: The mutant showed no enzymatic activity, as reported previously (20, 31). 

Phrase: "The mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no enzymatic activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2267219:Enzymatic Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(20,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: The activity in Sec12-NEP infectants was detectable and statistically significant (p < 0.05 as compared with the inactive mutant) but much lower than the others. 

Phrase: "The activity in Sec12-NEP infectants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1150197:neprilysin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detectable"

Phrase: "and"

Phrase: "statistically significant"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "as"

Phrase: "compared with the inactive mutant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205254:Inactive [Qualitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1707455:Compared [Activity]

Phrase: ")"

Phrase: "but"

Phrase: "much lower than the others."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
Processing 00000000.tx.101: However, this relatively low activity still seems to be sufficient to clear intracellular A (see below). 

Phrase: "However,"

Phrase: "this relatively low activity still"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "intracellular A ("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.102: Localization of Neprilysin Chimeras in NeuronsWe performed double immunofluorescence microscopy using organelle markers to confirm sorting of neprilysin chimeric proteins to an appropriate organelle (Fig. 3A). 

Phrase: "Localization of Neprilysin Chimeras"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "in NeuronsWe"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "double immunofluorescence microscopy"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
   755 E C0205288:Microscopic [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "organelle markers to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "sorting of neprilysin chimeric proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0887837:Protein Sorting [Cell Function]
   760   C0237886:Sorting [Mental Process]
   760   C0700314:sorting [Cell Function]
   760   C1947906:Sorting [Activity]

Phrase: "to an appropriate organelle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelle [Cell Component]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.103: The wild-type neprilysin showed a partial co-localization with each organelle marker protein (Fig. 3A, panels 1, 3, and 5), indicating that wild-type neprilysin is not exclusively transported to or retained in a particular compartment. 

Phrase: "The wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a partial co-localization with each organelle marker protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   762   C1660641:organelle localisation [Biologic Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "(Fig. 3A,"

Phrase: "panels 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "is"

Phrase: "not exclusively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "transported to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1550030:Transport To [Idea or Concept]
   799   C0005528:Transport, NOS [Cell Function]
   799   C1317949:Transport [Manufactured Object]
   799   C3495449:transport [Medical Device]

Phrase: "or"

Phrase: "retained in a particular compartment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0333118:Retained [Functional Concept]
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.104: Expression of our targeting constructs successfully sorted Sec12-NEP, ST-NEP, and TfR-NEP to the expected organelle in neurons as follows. 

Phrase: "Expression of our targeting constructs successfully sorted Sec12-NEP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "ST-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "TfR-NEP to the expected organelle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.105: Sec12-NEP was extensively distributed in cell somas, showing localization similar to that of ER marker BiP (Fig. 3A, panel 2). 

Phrase: "Sec12-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "was"

Phrase: "extensively"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "in cell somas,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0599444:Cell soma [Cell Component]
           somas
   884   C2752549:cell soma [Cell Component]
   793 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   755 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   727 E C2986476:Somatic [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "similar to that of ER marker BiP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 3A,"

Phrase: "panel 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.106: ST-NEP was detected overlapping with a TGN marker adaptin appearing as speckles near the nucleus (Fig. 3A, panel 4). 

Phrase: "ST-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "overlapping with a TGN marker adaptin appearing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0887838:trans-Golgi Network [Cell Component]
   764   C1179875:Golgi network [Cell Component]
   742   C0005516:Marker [Clinical Attribute]
   742   C0018042:Golgi [Cell Component]
   742   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   742   C1179085:Adaptin [Cell Component]
   742   C1513822:Network [Professional or Occupational Group]
   742   C1705739:Network [Manufactured Object]
   742   C1882071:Network [Conceptual Entity]
   742   C1948020:Overlapping [Conceptual Entity]
   742   C2826298:TRANS [Idea or Concept]
   708   C0700364:APPEAR [Qualitative Concept]

Phrase: "as speckles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0439691:Speckled [Qualitative Concept]

Phrase: "near the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 3A,"

Phrase: "panel 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.107: TfR-NEP was detected as vesicular structures throughout the cytoplasm, colocalizing with an early/recycling endosomes marker syntaxin 13 (Fig. 3A, panel 6). 

Phrase: "TfR-NEP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "was"

Phrase: "detected as vesicular structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205378:Vesicular [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C0678594:structures [Spatial Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "throughout the cytoplasm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "colocalizing with an early/recycling endosomes marker syntaxin 13"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0906203:Syntaxin 13 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C0887883:Early endosome [Cell Component]
   742   C0005516:Marker [Clinical Attribute]
   742   C0034850:Endosomes [Cell Component]
   742   C0282114:Recycling [Human-caused Phenomenon or Process]
   742   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1279919:Early [Temporal Concept]
   731   C2262706:recycling endosome [Cell Component]

Phrase: "(Fig. 3A,"

Phrase: "panel 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.108: The distributions of Sec12-NEP, ST-NEP, and TfR-NEP in the target organelles were increased 2.1-, 3.1-, and 2.1-fold, compared with those of wild-type neprilysin, respectively (p < 0.05). 

Phrase: "The distributions of Sec12-NEP,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0037775:Distributions [Spatial Concept]
   726 E C0520511:distribution [Idea or Concept]
   726 E C1704711:Distribution [Functional Concept]

Phrase: "ST-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "TfR-NEP in the target organelles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "were"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2.1-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "3.1-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "2.1-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "compared with those of wild-type neprilysin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   748   C1547052:*Type [Quantitative Concept]
   748   C1707455:Compared [Activity]

Phrase: "respectively"

Phrase: "(p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.109: We next examined targeting of GAP43-NEP to the lipid raft fraction by using sucrose gradient fractionation after 1% Triton X-100 extraction at 4 C (Fig. 3B). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "targeting of GAP43-NEP"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   853   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   774   C1159372:Protein Targeting [Molecular Function]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220844:growth [Physiologic Function]
   748   C0332281:Associated [Qualitative Concept]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   748   C1521840:Targeting [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "to the lipid raft fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C1167250:lipid raft [Cell Component]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "sucrose gradient fractionation after 1% Triton X-100 extraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0016640:fractionation [Laboratory Procedure]
   742   C0524811:fractionation [Therapeutic or Preventive Procedure]
   742   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "at 4 C (Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450365:3b [Intellectual Product]
   812   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.110: Flotilin-1, a marker protein of the lipid raft fraction, was detected as Triton X-100-insoluble proteins in fractions 4 and 5 (data not shown). 

Phrase: "Flotilin-1,"

Phrase: "a marker protein of the lipid raft fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected as Triton X-100-insoluble proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0242759:Triton [Geographic Area]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in fractions 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.111: GAP43-NEP as well as wild-type neprilysin were detected in the lipid raft fraction (Fig. 3B). 

Phrase: "GAP43-NEP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366499:NEPRILYSIN [Gene or Genome]
   771   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "as well as"

Phrase: "wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "detected in the lipid raft fraction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1167250:lipid raft [Cell Component]
   753   C0023779:Lipid [Lipid]
   753   C0336849:Raft [Manufactured Object]
   753   C0442726:Detected [Finding]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.112: The amount of GAP43-NEP in the raft fraction was 1.3-fold higher, compared with the case of wild-type neprilysin (p < 0.05). 

Phrase: "The amount of GAP43-NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "in the raft fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "1.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "compared with the case of wild-type neprilysin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C0868928:Case [Functional Concept]
   744   C1366499:NEPRILYSIN [Gene or Genome]
   744   C1547052:*Type [Quantitative Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   744   C1707455:Compared [Activity]

Phrase: "(p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.113: We did not employ the raft-targeting strategy described by Cailler et al. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "employ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0457083:Employ [Functional Concept]
  1000   C0557351:employ [Finding]

Phrase: "the raft-targeting strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategy [Mental Process]

Phrase: "described by Cailler et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.114: (32), in which a raft-targeting sequence was added at the C terminus of neprilysin, because such a modification may alter the conformation of the protein and thus may also modify the enzymatic properties of the peptidase. 

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "a raft-targeting sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "added at the C terminus of neprilysin,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   748   C1524062:Added [Functional Concept]
   714 E C1883712:Add [Functional Concept]

Phrase: "because"

Phrase: "such a modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the conformation of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0033625:Protein Conformation [Spatial Concept]
   760   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "may"

Phrase: "also"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the enzymatic properties of the peptidase."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]
Processing 00000000.tx.115: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.116: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.117: Subcellular localization of neprilysin and neprilysin chimeric proteins in neurons. 

Phrase: "Subcellular localization of neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "neprilysin chimeric proteins in neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.118: A, double immunofluorescence staining for neprilysin and organelle markers. 

Phrase: "A,"

Phrase: "double immunofluorescence staining for neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "organelle markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.119: Primary neurons transfected with wild-type neprilysin (panels 1, 3, and 5), Sec12-NEP (panel 2), ST-NEP (panel 4), and TfR-NEP (panel 6) were immunolabeled with antibodies to neprilysin (red) and organelle markers (green), BiP (panels 1 and 2), adaptin (panels 3 and 4), or syntaxin 13 (panels 5 and 6), respectively. 

Phrase: "Primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "transfected with wild-type neprilysin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1366499:NEPRILYSIN [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(panels 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Sec12-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(panel 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "ST-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(panel 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "TfR-NEP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "(panel 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "immunolabeled with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "organelle markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "BiP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "(panels 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "adaptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1179085:Adaptin [Cell Component]

Phrase: "(panels 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "syntaxin 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0906203:Syntaxin 13 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(panels 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "6"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.120: Bar, 20 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.121: We have confirmed that all the fluorescence signals were within a linear dynamic range of 4096 levels. 

Phrase: "We"

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "all the fluorescence signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were within a linear dynamic range of 4096 levels."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C2986743:Dynamic Range [Quantitative Concept]
   742   C0205132:Linear [Spatial Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C0729333:Dynamic [Functional Concept]
   742   C1514721:Range [Quantitative Concept]
   742   C2348147:Range [Quantitative Concept]
   742   C3542016:Range [Intellectual Product]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.122: B, for lipid raft fractionation, primary neurons transfected with wild-type neprilysin or GAP43-NEP were homogenized and fractionated into 13 fractions. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "for lipid raft fractionation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1446035:Lipid fractionation [Laboratory Procedure]
   827   C0016640:fractionation [Laboratory Procedure]
   827   C0524811:fractionation [Therapeutic or Preventive Procedure]
   827   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   734   C1167250:lipid raft [Cell Component]

Phrase: "primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "transfected with wild-type neprilysin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1366499:NEPRILYSIN [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "GAP43-NEP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366499:NEPRILYSIN [Gene or Genome]
   771   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "were"

Phrase: "homogenized"

Phrase: "and"

Phrase: "fractionated into 13 fractions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1264633:Fractions [Quantitative Concept]
   770   C1979893:Fractionated [Qualitative Concept]
   737 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.123: Fractions 4 and 5 are the lipid raft fraction as revealed by Western blot analysis using antibody to flotillin-1, a marker protein of lipid raft fraction (data not shown).  

Phrase: "Fractions 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "are"

Phrase: "the lipid raft fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C1167250:lipid raft [Cell Component]

Phrase: "as"

Phrase: "revealed by Western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0443289:Revealed [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody to flotillin-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a marker protein of lipid raft fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: We also investigated whether the expressed proteins appeared on the cell surface or not by performing immunofluorescence in the absence of Triton X-100. 

Phrase: "We also"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "the expressed proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appeared on the cell surface"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0700364:APPEAR [Qualitative Concept]

Phrase: "or"

Phrase: "not by performing immunofluorescence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   770   C1518422:Not [Functional Concept]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   901   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   827   C0242759:Triton [Geographic Area]
Processing 00000000.tx.125: Wild-type neprilysin, ST-NEP, TfR-NEP, and GAP43-NEP, but not Sec12-NEP, were observed on the cell surface (data not shown). 

Phrase: "Wild-type neprilysin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "ST-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "TfR-NEP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "and"

Phrase: "GAP43-NEP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366499:NEPRILYSIN [Gene or Genome]
   771   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "but"

Phrase: "not Sec12-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "were"

Phrase: "observed on the cell surface"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: Effect of Targeting of Neprilysin to Particular Intracellular Compartments on Intracellular and Extracellular A LevelsWe measured the amounts of A extracted with guanidine hydrochloride from the primary neurons expressing wild-type neprilysin, inactive mutant neprilysin, and neprilysin chimeric proteins (Fig. 4) in order to assess how much of the endogenously generated intracellular A was degraded. 

Phrase: "Effect of Targeting of Neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "to Particular Intracellular Compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]

Phrase: "on Intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "and"

Phrase: "Extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]

Phrase: "A LevelsWe"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the amounts of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "extracted with guanidine hydrochloride"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   770   C0018320:guanidine [Organic Chemical]
   770   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "from the primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "wild-type neprilysin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "inactive mutant neprilysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "neprilysin chimeric proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "how much of the endogenously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C1265611:How Much [Quantitative Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "intracellular A"

Phrase: "was"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.127: Both A40 and A42 were significantly decreased by the overexpression of wild-type neprilysin but not by that of inactive mutant neprilysin, as reported previously (20). 

Phrase: "Both A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased by the overexpression of wild-type neprilysin"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1366499:NEPRILYSIN [Gene or Genome]
   744   C1514559:Overexpression [Genetic Function]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "not by that of inactive mutant neprilysin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205254:Inactive [Qualitative Concept]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   748   C1518422:Not [Functional Concept]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.128: All the chimeric proteins degraded A40 to an extent indistinguishable from that of wild-type neprilysin. 

Phrase: "All"

Phrase: "the chimeric proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "A40 to an extent"

Phrase: "indistinguishable from that of wild-type neprilysin."
Processing 00000000.tx.129: A42 was much less degraded than A40 in all cases (010% versus 5060%). 

Phrase: "A42"

Phrase: "was"

Phrase: "much less"

Phrase: "degraded than A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "(010%"

Phrase: "versus"

Phrase: "5060%"

Phrase: ")."
Processing 00000000.tx.130: Our speculation on the reason for the preferential clearance of intracellular A40 as compared with A42 is that A40 may be retained intracellularly for a longer time than A42, for instance through a recycling mechanism. 

Phrase: "Our speculation on the reason"

Phrase: "for the preferential clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "of intracellular A40"

Phrase: "as"

Phrase: "compared with A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "is"

Phrase: "that A40"

Phrase: "may"

Phrase: "be"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "intracellularly for a longer time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "than A42,"

Phrase: "for instance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "through a recycling mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.131: This assumption is supported by the observation that ER-targeted neprilysin degrades A40 as sufficiently as wild type and other chimeras (see "Discussion" for further speculation). 

Phrase: "This assumption"

Phrase: "is"

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that ER-targeted neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "degrades"

Phrase: "A40"

Phrase: "as"

Phrase: "sufficiently as wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "other chimeras"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008109:Chimeras [Organism]
   966 E C1318484:Chimera [Disease or Syndrome]

Phrase: "(see ""Discussion"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: "for further speculation"

Phrase: ")."
Processing 00000000.tx.132: Most interesting, only wild-type neprilysin and ST-NEP degraded intracellular A42 to a significant degree. 

Phrase: "Most interesting, only wild-type neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "ST-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "intracellular A42 to a significant degree."
Processing 00000000.tx.133: This is presumably because A42 is not generated in or recycled back to the ER (see "Discussion") and because endosomes are somewhat too acidic for neprilysin, the optimum pH for which is neutral, to more efficiently degrade A than in TGN. 

Phrase: "This"

Phrase: "is"

Phrase: "presumably"

Phrase: "because"

Phrase: "A42"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "generated in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "or"

Phrase: "recycled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:recycled [Human-caused Phenomenon or Process]

Phrase: "back to the ER"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004600:Back [Body Location or Region]
   760   C0205095:Back [Spatial Concept]
   760   C0460009:Back [Body Location or Region]
   760   C1995000:Back [Body Location or Region]

Phrase: "(see ""Discussion"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: ")"

Phrase: "and"

Phrase: "because"

Phrase: "endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "are"

Phrase: "somewhat too acidic for neprilysin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001128:Acidic [Chemical]

Phrase: "the optimum pH for which"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]

Phrase: "is"

Phrase: "neutral, to more efficiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1882074:Neutral [Qualitative Concept]
   812   C2825492:Neutral [Phenomenon or Process]

Phrase: "degrade"

Phrase: "A than in TGN."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0887838:trans-Golgi Network [Cell Component]
   790   C1179875:Golgi network [Cell Component]
   753   C0018042:Golgi [Cell Component]
   753   C1513822:Network [Professional or Occupational Group]
   753   C1705739:Network [Manufactured Object]
   753   C1882071:Network [Conceptual Entity]
   753   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.134: View larger version (38K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.135: 4. 

Phrase: "4."
Processing 00000000.tx.136: Effects of neprilysin targeting to particular organelles or lipid raft fraction on the intracellular A40 and A42 levels. 

Phrase: "Effects of neprilysin targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "to particular organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]

Phrase: "or"

Phrase: "lipid raft fraction on the intracellular A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1264633:Fraction [Quantitative Concept]
   748   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "A42 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.137: The A40 and A42 levels extracted with guanidine hydrochloride from infected neurons were measured by sandwich ELISA. 

Phrase: "The A40"

Phrase: "and"

Phrase: "A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "extracted with guanidine hydrochloride"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   770   C0018320:guanidine [Organic Chemical]
   770   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "from infected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "measured by sandwich ELISA."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   853   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.138: The solid line shows the A levels of cells expressing inactive mutant neprilysin. 

Phrase: "The solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the A levels of cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "expressing"

Phrase: "inactive mutant neprilysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.139: Each column with an error bar represents the mean  S.D. of at least three independent experiments. 

Phrase: "Each column with an error bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  S.D."

Phrase: "of"

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.140: #, p < 0.01, significantly different from inactive mutant neprilysin by the Mann-Whitney U test.  

Phrase: "#,"

Phrase: "p < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "significantly different from inactive mutant neprilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "by the Mann-Whitney U test."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242927:Mann-Whitney U Test [Quantitative Concept]
   923   C1708930:Mann-Whitney Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
Processing 00000000.tx.141: We next examined the levels of A40 and A42 in the conditioned media of the infected cells (Fig. 5). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the levels of A40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A42 in the conditioned media of the infected cells"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.142: Overexpression of the wild-type neprilysin, ST-NEP, TfR-NEP, and GAP43-NEP significantly decreased the amounts of extracellular A40 and A42 in a comparable manner (p < 0.01). 

Phrase: "Overexpression of the wild-type neprilysin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "ST-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "TfR-NEP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "and"

Phrase: "GAP43-NEP significantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the amounts of extracellular A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "A42 in a comparable manner"

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.143: ST-NEP and TfR-NEP differed from the wild-type neprilysin by clearing A40 in a slightly but significantly less efficient manner (p < 0.01). 

Phrase: "ST-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "TfR-NEP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   734   C1619635:Transferrin Receptor [Immunologic Factor]

Phrase: "differed from the wild-type neprilysin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1366499:NEPRILYSIN [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "by clearing A40"

Phrase: "in a slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "but"

Phrase: "significantly less efficient manner"

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.144: Again, A42 was cleared to a lesser extent than A40 (60 versus 80%), but the difference was smaller than in the case of intracellular A clearance. 

Phrase: "Again,"

Phrase: "A42"

Phrase: "was"

Phrase: "cleared to a lesser extent"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0439792:Extent [Spatial Concept]
   760   C0521097:cleared [Functional Concept]
   760   C0547044:Lesser [Qualitative Concept]
   726 E C2963144:Clear [Qualitative Concept]

Phrase: "than A40"

Phrase: "(60"

Phrase: "versus"

Phrase: "80%"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "smaller than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0547044:Smaller [Qualitative Concept]
   833   C0700321:Smaller [Quantitative Concept]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "A clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.145: In contrast, Sec12-NEP, targeted to ER, exhibited much weaker activity to reduce the extracellular A (20%). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Sec12-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "targeted to ER,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   770   C1521840:Targeted [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "much weaker activity to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "reduce"

Phrase: "the extracellular A (20%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521119:Extracellular [Cell Component]

Phrase: ")."
Processing 00000000.tx.146: View larger version (37K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.148: Effects of neprilysin targeting to particular organelles or lipid raft fractions on the extracellular A40 and A42 levels. 

Phrase: "Effects of neprilysin targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "to particular organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]

Phrase: "or"

Phrase: "lipid raft fractions on the extracellular A40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "A42 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.149: The A40 and A42 levels in the conditioned medium of infected neurons were measured by sandwich ELISA. 

Phrase: "The A40"

Phrase: "and"

Phrase: "A42 levels in the conditioned medium of infected neurons"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by sandwich ELISA."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   853   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.150: The solid line shows the A levels of cells expressing inactive mutant neprilysin. 

Phrase: "The solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the A levels of cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "expressing"

Phrase: "inactive mutant neprilysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.151: Each column with an error bar represents the mean  S.D. of at least four independent experiments. 

Phrase: "Each column with an error bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  S.D."

Phrase: "of"

Phrase: "at least four independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.152: *, p < 0.01, significantly different from wild-type neprilysin; 

Phrase: "*,"

Phrase: "p < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "significantly different from wild-type neprilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.153: #, p < 0.01, significantly different from inactive mutant neprilysin by the Mann-Whitney U test.   

Phrase: "#,"

Phrase: "p < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "significantly different from inactive mutant neprilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "by the Mann-Whitney U test."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242927:Mann-Whitney U Test [Quantitative Concept]
   923   C1708930:Mann-Whitney Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
Processing 00000000.tx.154: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Despite a large number of cell biological studies of A metabolism and transport, it still remains unclear exactly where in neurons A is generated from amyloid precursor protein (APP). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES  Despite a large number of cell biological studies of A metabolism"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   751   C0007584:Cell Number [Laboratory Procedure]
   751   C0280606:metabolism studies [Diagnostic Procedure]
   751   C3274661:Reference Number [Intellectual Product]
   736   C0005532:Biological [Biomedical Occupation or Discipline]
   736   C0007634:Cell [Cell]
   736   C0025519:Metabolism [Organism Function]
   736   C0025520:metabolism [Functional Concept]
   736   C0205460:biological [Qualitative Concept]
   736   C0237753:*Number [Quantitative Concept]
   736   C0449788:Number [Quantitative Concept]
   736   C0549177:Large [Quantitative Concept]
   736   C0947630:studies [Laboratory Procedure]
   736   C1269647:Cell [Cell]
   736   C1514811:Reference [Idea or Concept]
   736   C1704653:Cell [Medical Device]
   736   C1706462:Reference [Conceptual Entity]
   736   C1948049:Cell [Spatial Concept]
   734   C2985663:Study Reference [Intellectual Product]
   703 E C0557651:Study [Manufactured Object]
   703 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "transport,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "it still"

Phrase: "remains"

Phrase: "unclear exactly where in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "A"

Phrase: "is"

Phrase: "generated from amyloid precursor protein (APP)."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
   760   C3146294:Generated [Activity]
Processing 00000000.tx.155: One of the aims of the present study was to obtain a clue to this question by targeting an A-degrading enzyme to particular cellular components. 

Phrase: "One of the aims of the present study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a clue to this question"

Phrase: "by targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "an A-degrading enzyme to particular cellular components."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
Processing 00000000.tx.156: The major technical limitation of our experimental paradigm employed here is that, although we can control the efficiency of infection by altering the amount of the viral vectors, the amount of protein expressed per cell cannot be controlled. 

Phrase: "The major technical limitation of our experimental paradigm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449295:Limitation [Functional Concept]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "here"

Phrase: "is"

Phrase: "that,"

Phrase: "although"

Phrase: "we"

Phrase: "can"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the efficiency of infection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013682:Efficiency [Quantitative Concept]

Phrase: "by altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the amount of the viral vectors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "the amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "expressed per cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007634:Cell [Cell]
   790   C1269647:Cell [Cell]
   790   C1704653:Cell [Medical Device]
   790   C1948049:Cell [Spatial Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "controlled."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.157: This limitation makes it somewhat difficult to interpret the results in a quantitative manner. 

Phrase: "This limitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:Limitation [Functional Concept]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it somewhat difficult to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332218:Difficult [Qualitative Concept]
   827   C2984079:Somewhat [Intellectual Product]
   755 E C1299586:Difficulty [Finding]

Phrase: "interpret"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpret [Functional Concept]

Phrase: "the results in a quantitative manner."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1709795:Quantitative Result [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.158: This assumption probably applies to the overexpression paradigm in most cell biological studies of APP and A metabolism thus far performed. 

Phrase: "This assumption probably"

Phrase: "applies to the overexpression paradigm"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0185125:Apply [Health Care Activity]
   760   C0681797:paradigm [Research Activity]
   760   C1514559:Overexpression [Genetic Function]
   760   C1632850:Apply [Functional Concept]
   760   C1879355:Apply [Functional Concept]

Phrase: "in most cell biological studies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0007634:Cell [Cell]
   827   C0205460:biological [Qualitative Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "A metabolism thus far"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   827   C0205108:far [Spatial Concept]

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.159: However, because the A clearance in each case, intracellular or extracellular, remained unsaturated (Figs. 4 and 5), the following qualitative considerations should at least be valid. 

Phrase: "However,"

Phrase: "because"

Phrase: "the A clearance in each case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "or"

Phrase: "extracellular,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]

Phrase: "remained"

Phrase: "unsaturated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522535:Unsaturated [Quantitative Concept]

Phrase: "(Figs. 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the following qualitative considerations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0518609:considerations [Finding]

Phrase: "should at least"

Phrase: "be"

Phrase: "valid."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2349099:Valid [Qualitative Concept]
   928 E C2349101:Validity [Quantitative Concept]
Processing 00000000.tx.160: We would like to comment on the difference in the ratio of A40 and A42 levels between the in vitro and in vivo situations. 

Phrase: "We"

Phrase: "would like"

Phrase: "to comment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282411:Comment [Intellectual Product]
  1000   C0947611:Comment [Intellectual Product]

Phrase: "on the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "in the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "of A40"

Phrase: "and"

Phrase: "A42 levels between the in vitro"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "in vivo situations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.161: The ratio is 7:1 in vitro and 3:1 in vivo (27). 

Phrase: "The ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "is"

Phrase: "7"

Phrase: ":"

Phrase: "1 in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1 in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.162: This difference is presumably due to the difference in the volume of the extracellular space and in the complexity of axo-dendritic structure and connections. 

Phrase: "This difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "is"

Phrase: "presumably due to the difference"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "in the volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: "of the extracellular space"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015352:Extracellular Space [Body Space or Junction]
   861   C1883067:Space [Spatial Concept]

Phrase: "and in the complexity of axo-dendritic structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0011305:Dendritic [Cell Component]
   744   C0439640:Dendritic [Qualitative Concept]
   744   C0678594:Structure [Spatial Concept]
   744   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "connections."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449379:connections [Intellectual Product]
Processing 00000000.tx.163: Therefore, a simple enzymatic explanation for the observation indicating that A40 was more efficiently degraded than A42 in the present in vitro experimental paradigm (Figs. 4 and 5) is that the affinity of neprilysin for A42 is indistinguishable from that for A40 (26), and that the substrate present in a larger amount has a greater chance of encountering the enzyme. 

Phrase: "Therefore,"

Phrase: "a simple enzymatic explanation for the observation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "indicating"

Phrase: "that A40"

Phrase: "was"

Phrase: "more efficiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "degraded than A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in the present in vitro experimental paradigm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0681797:paradigm [Research Activity]

Phrase: "(Figs. 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "that"

Phrase: "the affinity of neprilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for A42"

Phrase: "is"

Phrase: "indistinguishable from that"

Phrase: "for A40"

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "that"

Phrase: "the substrate present in a larger amount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "has"

Phrase: "a greater chance of encountering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0237506:Chance [Qualitative Concept]

Phrase: "the enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.164: In contrast, A40 and A42 are degraded to an essentially identical extent in the brain in vivo as indicated by reverse genetic evidence (4). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "A40"

Phrase: "and"

Phrase: "A42"

Phrase: "are"

Phrase: "degraded to an essentially identical extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205280:Identical [Qualitative Concept]
   753   C0439792:Extent [Spatial Concept]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "as"

Phrase: "indicated by reverse genetic evidence"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C0332120:Evidence [Functional Concept]
   760   C1444656:Indicated [Finding]
   760   C1555029:Reverse [Idea or Concept]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.165: Most interesting, infusion of a cell-impermeable neprilysin inhibitor, thiorphan, into the brain elevated A42 but not A40 in the insoluble fraction (33). 

Phrase: "Most interesting, infusion of a cell-impermeable neprilysin inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0574032:Infusion [Therapeutic or Preventive Procedure]
   742   C1827465:Infusion [Functional Concept]

Phrase: "thiorphan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "into the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "A42"

Phrase: "but"

Phrase: "not A40 in the insoluble fraction"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.166: These previous observations, together with the finding that the relative efficiency of A42 degradation versus A40 degradation is greater extracellularly than intracellularly, imply that A40 and A42 are somewhat differentially metabolized in spatial terms. 

Phrase: "These previous observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "together with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the relative efficiency of A42 degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0013682:Efficiency [Quantitative Concept]
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "versus"

Phrase: "A40 degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "greater extracellularly than intracellularly,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "imply"

Phrase: "that A40"

Phrase: "and"

Phrase: "A42"

Phrase: "are"

Phrase: "somewhat differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2984079:Somewhat [Intellectual Product]

Phrase: "metabolized in spatial terms."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1428114:spatial [Gene or Genome]
   770   C1524026:Metabolized [Cell Function]
   737   C1515273:Term [Temporal Concept]
   737   C1705313:Term [Idea or Concept]
   737   C2826302:TERM [Intellectual Product]
Processing 00000000.tx.167: Degradation of A42 seems to be more closely associated with the outside surface of the cell than that of A40. 

Phrase: "Degradation of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more closely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "associated with the outside surface of the cell"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   793   C0699040:Surface of cell [Cell Component]
           Cell surface
           cell associated
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0007634:Cell [Cell]
   744   C0205101:Outside [Spatial Concept]
   744   C0205148:Surface [Spatial Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "than that"

Phrase: "of A40."
Processing 00000000.tx.168: The "outside surface" probably corresponds to the presynaptic membrane in vivo (27, 34). 

Phrase: "The ""outside surface"" probably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205101:Outside [Spatial Concept]
   827   C0205148:Surface [Spatial Concept]
   827   C0750492:Probably [Idea or Concept]

Phrase: "corresponds to the presynaptic membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1325748:pre-synaptic membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(27,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.169: Among the four chimeric proteins examined in the present study, only Sec12-NEP, targeted to ER, was significantly less abundantly detected than wild-type neprilysin in terms of both protein quantity and enzymatic activity. 

Phrase: "Among the four chimeric proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "examined in the present study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0332128:Examined [Finding]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "only Sec12-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "targeted to ER,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   770   C1521840:Targeted [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "was"

Phrase: "significantly less abundantly"

Phrase: "detected than wild-type neprilysin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332307:Type [Qualitative Concept]
   760   C0442726:Detected [Finding]
   760   C0445392:Wild [Intellectual Product]
   760   C1366499:NEPRILYSIN [Gene or Genome]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "in terms of both protein quantity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1265611:Quantity [Quantitative Concept]
   861   C1554108:Quantity [Intellectual Product]
   861   C1561573:Quantity [Intellectual Product]

Phrase: "and"

Phrase: "enzymatic activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2267219:Enzymatic Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.170: As discussed under "Results," this is likely to have been caused by metabolic instability of this chimera, which may be accounted for by premature glycosylation, because Sec12-NEP, but not the others, was sensitive to endoglycosidase H treatment (data not shown). 

Phrase: "As"

Phrase: "discussed under ""Results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: """"

Phrase: "this"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "caused by metabolic instability of this chimera,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0008109:Chimera [Organism]
   748   C0311400:Metabolic [Functional Concept]
   748   C1262946:Chimaera [Fish]
   748   C1318484:Chimera [Disease or Syndrome]
   748   C1444783:Instability [Finding]
   748   C1524026:Metabolic [Cell Function]
   748   C2707259:Metabolic [Clinical Attribute]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by premature glycosylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017982:glycosylation [Natural Phenomenon or Process]
   861   C0376322:Glycosylation [Molecular Function]

Phrase: "because"

Phrase: "Sec12-NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the others,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "was"

Phrase: "sensitive to endoglycosidase H treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.171: Nevertheless, expression of Sec12-NEP reduced intracellular A40 in a manner comparable with that of wild-type neprilysin and the other chimeras. 

Phrase: "Nevertheless,"

Phrase: "expression of Sec12-NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "intracellular A40 in a manner"

Phrase: "comparable with that of wild-type neprilysin"

Phrase: "and"

Phrase: "the other chimeras."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008109:Chimeras [Organism]
   966 E C1318484:Chimera [Disease or Syndrome]
Processing 00000000.tx.172: This indicates that the relatively small activity of neprilysin expressed in ER was sufficient to degrade intracellular A40, because wild-type neprilysin and all the other chimeras reside at least transiently in the ER after synthesis. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the relatively small activity of neprilysin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1150197:neprilysin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "expressed in ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "degrade"

Phrase: "intracellular A40,"

Phrase: "because"

Phrase: "wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "all the"

Phrase: "other chimeras"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008109:Chimeras [Organism]
   966 E C1318484:Chimera [Disease or Syndrome]

Phrase: "reside at least transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2982691:Reside [Activity]

Phrase: "in the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "after synthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]
Processing 00000000.tx.173: Considering the previous reports describing A generation in ER, TGN, and endosome (14, 15, 35), our observation implies that a certain pool of intracellular A40 is retained in or recycled back to the ER in cultured neurons, as it is unlikely that the ER is a major site of A generation from APP (36). 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "describing"

Phrase: "A generation in ER,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "TGN,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "and"

Phrase: "endosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosome [Cell Component]

Phrase: "(14,"

Phrase: "15,"

Phrase: "35"

Phrase: ")"

Phrase: ","

Phrase: "our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "implies"

Phrase: "that"

Phrase: "a certain pool of intracellular A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "is"

Phrase: "retained in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0333118:Retained [Functional Concept]

Phrase: "or"

Phrase: "recycled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:recycled [Human-caused Phenomenon or Process]

Phrase: "back to the ER"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004600:Back [Body Location or Region]
   760   C0205095:Back [Spatial Concept]
   760   C0460009:Back [Body Location or Region]
   760   C1995000:Back [Body Location or Region]

Phrase: "in cultured neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as"

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "is"

Phrase: "a major site of A generation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "from APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.174: If aging causes such a pool of intracellular A to remain abnormally unmetabolized, pathological intraneuronal A accumulation (3739) may arise, possibly leading to ER stresses. 

Phrase: "If"

Phrase: "aging causes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015127:causes [Functional Concept]
   861   C1314792:Causes [Functional Concept]
   827 E C1524003:Cause [Conceptual Entity]

Phrase: "such a pool of intracellular A to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0337051:Pool [Geographic Area]
   748   C1509144:pool [Clinical Attribute]
   748   C2349200:Pool [Functional Concept]

Phrase: "remain"

Phrase: "abnormally unmetabolized, pathological intraneuronal"

Phrase: "A accumulation"

Phrase: "(3739"

Phrase: ")"

Phrase: "may"

Phrase: "arise"

Phrase: ","

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "leading to ER stresses."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   862   C3178870:Stresses, Endoplasmic Reticulum [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726   C0038435:Stress [Finding]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.175: Part of this ER-resident A may be transported to the cytoplasm and undergo degradation catalyzed by proteosome or insulin-degrading enzyme (40). 

Phrase: "Part of this ER-resident A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C1179923:Part of endoplasmic reticulum [Cell Component]
           endoplasmic reticulum part
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "transported to the cytoplasm"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C1550030:Transport To [Idea or Concept]
   770   C0010834:Cytoplasm [Cell Component]
   767   C1159563:Cytoplasmic transport [Cell Function]
   737   C0005528:Transport, NOS [Cell Function]
   737   C1317949:Transport [Manufactured Object]
   737   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "undergo"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "catalyzed by proteosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0208355:Proteosome [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.176: Of particular interest is the fact that intracellular A42 was cleared significantly only by wild-type neprilysin and TGN-targeted ST-NEP (Fig. 4). 

Phrase: "Of particular interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:Interest [Mental Process]

Phrase: "is"

Phrase: "the fact"

Phrase: "that intracellular A42"

Phrase: "was"

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "significantly only by wild-type neprilysin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205171:Only [Quantitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1366499:NEPRILYSIN [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "TGN-targeted ST-NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.177: This observation is consistent with our speculation that metabolism of A42 takes place somewhat later than that of A40 in the intracellular trafficking processes. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "consistent with our speculation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that metabolism of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "somewhat later than that of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0205087:Late [Temporal Concept]

Phrase: "in the intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.178: In clear contrast to intracellular A, extracellular A was poorly degraded by Sec12-NEP, which did not appear on the cell surface. 

Phrase: "In clear contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "to intracellular A,"

Phrase: "extracellular A"

Phrase: "was"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "degraded by Sec12-NEP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1366499:NEPRILYSIN [Gene or Genome]
   770   C1418883:SEC12 [Gene or Genome]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "which"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear on the cell surface."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0700364:APPEAR [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.179: Because the wild-type neprilysin and all the other chimeras were detected on the outside of neurons, the results indicate that the majority of extracellular A degradation takes place on the cell surface in the present experimental paradigm. 

Phrase: "Because"

Phrase: "the wild-type neprilysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:NEPRILYSIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "all the"

Phrase: "other chimeras"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008109:Chimeras [Organism]
   966 E C1318484:Chimera [Disease or Syndrome]

Phrase: "were"

Phrase: "detected on the outside of neurons,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0027882:Neurons [Cell]
   753   C0205101:Outside [Spatial Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the majority of extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "A degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place on the cell surface"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442504:Place [Spatial Concept]
   760   C1704765:Place [Functional Concept]
   760   C1882509:Place [Activity]
   760   C3496241:place [Disease or Syndrome]

Phrase: "in the present experimental paradigm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681797:paradigm [Research Activity]
Processing 00000000.tx.180: It was rather unexpected that GAP43-NEP, targeted to lipid rafts, failed to degrade A more efficiently than wild-type neprilysin, because a number of studies have indicated that A generation takes place in this microdomain (18, 19). 

Phrase: "It"

Phrase: "was"

Phrase: "rather unexpected"

Phrase: "that GAP43-NEP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366499:NEPRILYSIN [Gene or Genome]
   771   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "targeted to lipid rafts,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1167250:lipid rafts [Cell Component]
   770   C0023779:Lipid [Lipid]
   770   C1521840:Targeted [Functional Concept]
   737   C0336849:Raft [Manufactured Object]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "A more efficiently than wild-type neprilysin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "because"

Phrase: "a number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place in this microdomain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442504:Place [Spatial Concept]
   770   C1704765:Place [Functional Concept]
   770   C1882509:Place [Activity]
   770   C3496241:place [Disease or Syndrome]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.181: The results can be accounted for by assuming that the extracellular A was proteolyzed by neprilysin after being secreted into the conditioned medium in the present in vitro paradigm. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "can"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by"

Phrase: "assuming"

Phrase: "that"

Phrase: "the extracellular A"

Phrase: "was"

Phrase: "proteolyzed by neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "after"

Phrase: "being"

Phrase: "secreted into the conditioned medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0439536:Medium [Quantitative Concept]
   760   C1327616:Secreted [Cell Function]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "in the present in vitro paradigm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0681797:paradigm [Research Activity]
Processing 00000000.tx.182: We would like to draw attention to the fact that that although the ratio of soluble A to insoluble A is 400:1 in vitro, the ratio in vivo is 3:1 (27). 

Phrase: "We"

Phrase: "would like to"

Phrase: "draw"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013113:Draw [Intellectual Product]

Phrase: "attention to the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004268:Attention [Mental Process]

Phrase: "that"

Phrase: "that"

Phrase: "although"

Phrase: "the ratio of soluble A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to insoluble A"

Phrase: "is"

Phrase: "400"

Phrase: ":"

Phrase: "1 in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: "the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "is"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.183: Therefore, there still remains a possibility that targeting neprilysin to lipid rafts may improve the efficiency of A degradation under in vivo conditions, in which both neprilysin and A are axonally transported to presynapses (27, 34, 4144), and A is likely to associate with such raft components as ganglioside and cholesterol (45, 46) and such raft-interacting proteins as apolipoproteins J and E (4750). 

Phrase: "Therefore,"

Phrase: "there still"

Phrase: "remains"

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that targeting neprilysin to lipid rafts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "may"

Phrase: "improve"

Phrase: "the efficiency of A degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013682:Efficiency [Quantitative Concept]

Phrase: "under in vivo conditions,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C1515655:In Vivo [Spatial Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in which"

Phrase: "both neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "A"

Phrase: "are"

Phrase: "axonally"

Phrase: "transported to presynapses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   866   C1550030:Transport To [Idea or Concept]
   756   C0005528:Transport, NOS [Cell Function]
   756   C1317949:Transport [Manufactured Object]
   756   C3495449:transport [Medical Device]

Phrase: "(27,"

Phrase: "34,"

Phrase: "4144"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "associate with such raft components"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0336849:Raft [Manufactured Object]
   760   C0449432:Components [Manufactured Object]
   760   C0750490:Associate [Idea or Concept]
   760   C1706221:Associate [Professional or Occupational Group]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "as ganglioside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017082:Ganglioside [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "(45,"

Phrase: "46"

Phrase: ")"

Phrase: "and"

Phrase: "such raft-interacting proteins as apolipoproteins J"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "E (4750"

Phrase: ")."
Processing 00000000.tx.184: One way to further examine this possibility would be to utilize the in vivo gene transfer approach (27).  

Phrase: "One way to further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "examine"

Phrase: "this possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "utilize"

Phrase: "the in vivo gene transfer approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0449445:Approach [Spatial Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.185: FOOTNOTES  * This work was supported by research grants from RIKEN Brain Science Institute and the Ministry of Education, Culture, Sports, Science and Technology of Japan. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by research grants"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0260206:Research Grants [Research Activity]
   819   C0035176:research supported [Quantitative Concept]
   770   C0018173:Grants [Quantitative Concept]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]
   737 E C1548284:Grant [Idea or Concept]

Phrase: "from RIKEN Brain Science Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "the Ministry of Education,"

Phrase: "Culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology of Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0039421:Technology [Occupation or Discipline]
Processing 00000000.tx.186: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.187: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.188: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.189: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.190: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.191: 81-48-467-9715; 

Phrase: "81-48-467-9715"

Phrase: ";"
Processing 00000000.tx.192: Fax: 81-48-467-9716; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "81-48-467-9716"

Phrase: ";"
Processing 00000000.tx.193: E-mail: saido{at}brain.riken.go.jp . 1 The abbreviations used are: A, amyloid peptide; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "saido{at}brain.riken."

Phrase: "go.jp . 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1422482:JP-1 [Gene or Genome]
   827   C1822658:GO [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A,"

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.194: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.195: ER, endoplasmic reticulum; 

Phrase: "ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ";"
Processing 00000000.tx.196: TGN, trans-Golgi network; 

Phrase: "TGN,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "trans-Golgi network"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.197: ST, -galactoside 2,6-sialyltransferase; 

Phrase: "ST, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037039:sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0163611:Sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "galactoside 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016956:galactoside [Carbohydrate]

Phrase: "6-sialyltransferase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037039:sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0163611:Sialyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.198: TfR, transferrin receptor; 

Phrase: "TfR,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
  1000   C1619635:Transferrin Receptor [Immunologic Factor]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "transferrin receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
  1000   C1619635:Transferrin Receptor [Immunologic Factor]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.199: GAP43, growth-associated protein 43; 

Phrase: "GAP43,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "growth-associated protein 43"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.200: SFV, Semliki Forest virus; 

Phrase: "SFV,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036636:Semliki forest virus [Virus]
   827   C0042776:Virus [Virus]
   827   C0086312:Forest [Geographic Area]
   827   C0319157:virus [Virus]

Phrase: "Semliki Forest virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036636:Semliki forest virus [Virus]
   827   C0042776:Virus [Virus]
   827   C0086312:Forest [Geographic Area]
   827   C0319157:virus [Virus]

Phrase: ";"
Processing 00000000.tx.201: BiP, immunoglobulin heavy chain-binding protein; 

Phrase: "BiP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "immunoglobulin heavy chain-binding protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0063423:immunoglobulin heavy chain-binding protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415761:IMMUNOGLOBULIN HEAVY CHAIN-BINDING PROTEIN [Gene or Genome]
   911   C1412030:Immunoglobulin Binding Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1149306:immunoglobulin binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   717   C0021034:Immunoglobulin Heavy Chain [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.202: MAP-2, microtubule-associated protein-2; 

Phrase: "MAP-2,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0024773:Microtubule-Associated Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417006:MICROTUBULE-ASSOCIATED PROTEIN 2 [Gene or Genome]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "microtubule-associated protein-2"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0024773:Microtubule-Associated Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417006:MICROTUBULE-ASSOCIATED PROTEIN 2 [Gene or Genome]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.203: NEP, neprilysin; 

Phrase: "NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.204: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.205: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.206: MES, 2-(N-morpholino)ethanesulfonic acid. 

Phrase: "MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265215:MES [Congenital Abnormality]
  1000   C1417092:MES [Gene or Genome]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(N-morpholino"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881903:Morpholino [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "ethanesulfonic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206794:ethanesulfonic acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.207: 2 N. 

Phrase: "2 N."
Processing 00000000.tx.208: Iwata and T. 

Phrase: "Iwata"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.209: C. 

Phrase: "C."
Processing 00000000.tx.210: Saido, unpublished data.  

Phrase: "Saido,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.211: ACKNOWLEDGMENTS  We thank E. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "E."
Processing 00000000.tx.212: Hosoki for technical assistance. 

Phrase: "Hosoki for technical assistance."
Processing 00000000.tx.213: We also thank Dr. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.214: Y. 

Phrase: "Y."
Processing 00000000.tx.215: Ihara for kindly providing the rabbit anti-rat MAP-2 antiserum, Dr. 

Phrase: "Ihara for kindly"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "the rabbit anti-rat MAP-2 antiserum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   723   C1455604:microtubule-associated protein 2, rat [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.216: Y. 

Phrase: "Y."
Processing 00000000.tx.217: Hashimoto for rat ST cDNA, Dr. 

Phrase: "Hashimoto for rat ST cDNA,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.218: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.219: De Strooper for the viral vector, Takeda Chemical Industries, Ltd. for the monoclonal antibodies to A for ELISA, and Dr. 

Phrase: "De Strooper for the viral vector,"

Phrase: "Takeda Chemical Industries,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007983:Industries, Chemical [Organization]
   827   C0021267:Industries [Occupational Activity]

Phrase: "Ltd."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1136140:LTD [Organ or Tissue Function]

Phrase: "for the monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to A for ELISA,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   937   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   875   C2717977:Enzyme Assay [Laboratory Procedure]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   771   C1517892:Link [Intellectual Product]
   771   C1704666:Link [Intellectual Product]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.220: A. 

Phrase: "A."
Processing 00000000.tx.221: Nakano for advice about organelle targeting.  

Phrase: "Nakano for advice"

Phrase: "about organelle targeting."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521840:Targeting [Functional Concept]
   827 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.222: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Selkoe, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.223: J. 

Phrase: "J."
Processing 00000000.tx.224: (2001) Physiol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Physiol."
Processing 00000000.tx.225: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.226: 81, 741766[Abstract/Free FullText] Saido, T. 

Phrase: "81,"

Phrase: "741766"

Phrase: "[Abstract/Free FullText"

Phrase: "] Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.227: C. 

Phrase: "C."
Processing 00000000.tx.228: (2000) Neurosci. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.229: News 3, 5262 Hardy, J. 

Phrase: "News 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282425:News [Intellectual Product]

Phrase: "5262 Hardy,"

Phrase: "J."
Processing 00000000.tx.230: (1997) Trends Neurosci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.231: 20, 154159[CrossRef][Medline] [OrderarticleviaInfotrieve] Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. 

Phrase: "20,"

Phrase: "154159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.232: P., Gerard, C., Hama, E., Lee, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.233: J., and Saido, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.234: C. 

Phrase: "C."
Processing 00000000.tx.235: (2001) Science 292, 15501552[Abstract/Free FullText] Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 292,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "15501552"

Phrase: "[Abstract/Free FullText"

Phrase: "] Farris,"

Phrase: "W.,"

Phrase: "Mansourian,"

Phrase: "S."

Phrase: ","

Phrase: "Chang,"

Phrase: "Y.,"

Phrase: "Lindsley,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "E."
Processing 00000000.tx.236: A., Frosch, M. 

Phrase: "A.,"

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.237: P., Eckman, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.238: B., Tanzi, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.239: E., Selkoe, D. 

Phrase: "E.,"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.240: J., and Guenette, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.241: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.242: Natl. 

Phrase: "Natl."
Processing 00000000.tx.243: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.244: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.245: U. 

Phrase: "U."
Processing 00000000.tx.246: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.247: A. 

Phrase: "A."
Processing 00000000.tx.248: 100, 41624167[Abstract/Free FullText] Miller, B. 

Phrase: "100,"

Phrase: "41624167"

Phrase: "[Abstract/Free FullText"

Phrase: "] Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.249: C., Eckman, E. 

Phrase: "C., Eckman,"

Phrase: "E."
Processing 00000000.tx.250: A., Sambamurti, K., Dobbs, N., Chow, K. 

Phrase: "A.,"

Phrase: "Sambamurti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dobbs,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Chow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.251: M., Eckman, C. 

Phrase: "M."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.252: B., Hersh, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.253: B., and Thiele, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Thiele,"

Phrase: "D."
Processing 00000000.tx.254: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.255: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.256: Natl. 

Phrase: "Natl."
Processing 00000000.tx.257: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.258: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.259: U. 

Phrase: "U."
Processing 00000000.tx.260: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.261: A. 

Phrase: "A."
Processing 00000000.tx.262: 100, 62216226[Abstract/Free FullText] Eckman, E. 

Phrase: "100,"

Phrase: "62216226"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eckman,"

Phrase: "E."
Processing 00000000.tx.263: A., Watson, M., Marlow, L., Sambamurti, K., and Eckman, C. 

Phrase: "A.,"

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Marlow,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sambamurti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.264: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.265: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.266: Biol. 

Phrase: "Biol."
Processing 00000000.tx.267: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.268: 278, 20812084[Abstract/Free FullText] Saito, T., Takaki, Y., Iwata, N., Trojanowski, J., and Saido, T. 

Phrase: "278,"

Phrase: "20812084"

Phrase: "[Abstract/Free FullText"

Phrase: "] Saito,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.269: C. 

Phrase: "C."
Processing 00000000.tx.270: (2003) Sci. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.271: Aging Knowledge Environ. 

Phrase: "Aging Knowledge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376554:Knowledge [Intellectual Product]

Phrase: "Environ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1568941:Environ [Organic Chemical]
Processing 00000000.tx.272: 2003 3:PE1 Saido, T. 

Phrase: "2003 3"

Phrase: ":"

Phrase: "PE1 Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.273: C., and Nakahara, H. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Nakahara,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.274: (2003) in A Metabolism and Alzheimer's Disease (Saido, T. C., ed) pp. 

Phrase: "(2003"

Phrase: ")"

Phrase: "in A Metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(Saido,"

Phrase: "T. C., ed) pp."
Processing 00000000.tx.275: 6180, Landes Bioscience, Georgetown, TX Saria, A., Hauser, K. 

Phrase: "6180,"

Phrase: "Landes Bioscience,"

Phrase: "Georgetown,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553268:Georgetown [Population Group]
  1000   C1555201:Georgetown [Population Group]

Phrase: "TX Saria,"

Phrase: "A.,"

Phrase: "Hauser,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.276: F., Traurig, H. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Traurig,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.277: H., Turbek, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Turbek,"

Phrase: "C."
Processing 00000000.tx.278: S., Hersh, L., and Gerard, C. 

Phrase: "S."

Phrase: ","

Phrase: "Hersh,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Gerard,"

Phrase: "C."
Processing 00000000.tx.279: (1997) Neurosci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.280: Lett. 

Phrase: "Lett."
Processing 00000000.tx.281: 234, 2730[CrossRef][Medline] [OrderarticleviaInfotrieve] Iwata, N., Takaki, Y., Fukami, S., Tsubuki, S., and Saido, T. 

Phrase: "234,"

Phrase: "2730"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Fukami,"

Phrase: "S."

Phrase: ","

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.282: C. 

Phrase: "C."
Processing 00000000.tx.283: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.284: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.285: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.286: 70, 493500[CrossRef][Medline] [OrderarticleviaInfotrieve] Yasojima, K., Akiyama, H., McGeer, E. 

Phrase: "70,"

Phrase: "493500"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yasojima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Akiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "McGeer,"

Phrase: "E."
Processing 00000000.tx.287: G., and McGeer, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "McGeer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.288: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.289: (2001) Neurosci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.290: Lett. 

Phrase: "Lett."
Processing 00000000.tx.291: 297, 97100[CrossRef][Medline] [OrderarticleviaInfotrieve] Yasojima, K., McGeer, E. 

Phrase: "297,"

Phrase: "97100"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yasojima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "McGeer,"

Phrase: "E."
Processing 00000000.tx.292: G., and McGeer, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "McGeer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.293: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.294: (2001) Brain Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.295: 919, 115121[CrossRef][Medline] [OrderarticleviaInfotrieve] Echeverria, V., and Cuello, A. 

Phrase: "919,"

Phrase: "115121"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Echeverria,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Cuello,"

Phrase: "A."
Processing 00000000.tx.296: C. 

Phrase: "C."
Processing 00000000.tx.297: (2002) Mol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.298: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.299: 26, 299316[CrossRef][Medline] [OrderarticleviaInfotrieve] Ling, Y., Morgan, K., and Kalsheker, N. 

Phrase: "26,"

Phrase: "299316"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "Y.,"

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kalsheker,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.300: (2003) Int. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.301: J. 

Phrase: "J."
Processing 00000000.tx.302: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.303: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.304: 35, 15051535[CrossRef][Medline] [OrderarticleviaInfotrieve] Angelisova, P., Drbal, K., Horejsi, V., and Cerny, J. 

Phrase: "35,"

Phrase: "15051535"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Angelisova,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Drbal,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Horejsi,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Cerny,"

Phrase: "J."
Processing 00000000.tx.305: (1999) Blood 93, 14371439[Free FullText] Kanemitsu, H., Tomiyama, T., and Mori, H. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Blood 93,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "14371439"

Phrase: "[Free FullText"

Phrase: "] Kanemitsu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tomiyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Mori,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.306: (2003) Neurosci. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.307: Lett. 

Phrase: "Lett."
Processing 00000000.tx.308: 23, 113116 Wolozin, B. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "113116 Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.309: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.310: Natl. 

Phrase: "Natl."
Processing 00000000.tx.311: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.312: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.313: U. 

Phrase: "U."
Processing 00000000.tx.314: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.315: A. 

Phrase: "A."
Processing 00000000.tx.316: 98, 53715373[Free FullText] Cordy, J. 

Phrase: "98,"

Phrase: "53715373"

Phrase: "[Free FullText"

Phrase: "] Cordy,"

Phrase: "J."
Processing 00000000.tx.317: M., Hussain, I., Dingwall, C., Hooper, N. 

Phrase: "M."

Phrase: ","

Phrase: "Hussain,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Dingwall,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hooper,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.318: M., and Turner, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.319: J. 

Phrase: "J."
Processing 00000000.tx.320: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.321: Natl. 

Phrase: "Natl."
Processing 00000000.tx.322: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.323: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.324: U. 

Phrase: "U."
Processing 00000000.tx.325: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.326: A. 

Phrase: "A."
Processing 00000000.tx.327: 100, 1173511740[Abstract/Free FullText] Hama, E., Shirotani, K., Masumoto, H., Sekine-Aizawa, Y., Aizawa, H., and Saido, T. 

Phrase: "100,"

Phrase: "1173511740"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masumoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sekine-Aizawa,"

Phrase: "Y.,"

Phrase: "Aizawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.328: C. 

Phrase: "C."
Processing 00000000.tx.329: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.330: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.331: (Tokyo) 130, 721726[Abstract] Sato, M., Sato, K., and Nakano, A. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "130,"

Phrase: "721726"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sato,"

Phrase: "M."

Phrase: ","

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Nakano,"

Phrase: "A."
Processing 00000000.tx.332: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.333: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.334: 134, 279293[Abstract] Colley, K. 

Phrase: "134,"

Phrase: "279293"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Colley,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.335: J., Lee, E. 

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "E."
Processing 00000000.tx.336: U., and Paulson, J. 

Phrase: "U.,"

Phrase: "and"

Phrase: "Paulson,"

Phrase: "J."
Processing 00000000.tx.337: C. 

Phrase: "C."
Processing 00000000.tx.338: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.339: Biol. 

Phrase: "Biol."
Processing 00000000.tx.340: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.341: 267, 77847793[Abstract/Free FullText] West, A. 

Phrase: "267,"

Phrase: "77847793"

Phrase: "[Abstract/Free FullText"

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A."
Processing 00000000.tx.342: E., Neve, R. 

Phrase: "E.,"

Phrase: "Neve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.343: L., and Buckley, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Buckley,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.344: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.345: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.346: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.347: 17, 60386047[Abstract/Free FullText] Arni, S., Keilbaugh, S. 

Phrase: "17,"

Phrase: "60386047"

Phrase: "[Abstract/Free FullText"

Phrase: "] Arni,"

Phrase: "S."

Phrase: ","

Phrase: "Keilbaugh,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.348: A., Ostermeyer, A. 

Phrase: "A.,"

Phrase: "Ostermeyer,"

Phrase: "A."
Processing 00000000.tx.349: G., and Brown, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "D."
Processing 00000000.tx.350: A. 

Phrase: "A."
Processing 00000000.tx.351: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.352: Biol. 

Phrase: "Biol."
Processing 00000000.tx.353: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.354: 273, 2847828485[Abstract/Free FullText] Nukina, N., and Ihara, Y. 

Phrase: "273,"

Phrase: "2847828485"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.355: (1983) Proc. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.356: Jpn. 

Phrase: "Jpn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:JPN [Geographic Area]
Processing 00000000.tx.357: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.358: 59, 284287 Shirotani, K., Tsubuki, S., Iwata, N., Takaki, Y., Harigaya, W., Maruyama, K., Kiryu-Seo, S., Kiyama, H., Iwata, H., Tomita, T., Iwatsubo, T., and Saido, T. 

Phrase: "59,"

Phrase: "284287 Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Harigaya,"

Phrase: "W.,"

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kiryu-Seo,"

Phrase: "S."

Phrase: ","

Phrase: "Kiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Iwata,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.359: C. 

Phrase: "C."
Processing 00000000.tx.360: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.361: Biol. 

Phrase: "Biol."
Processing 00000000.tx.362: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.363: 276, 2189521901[Abstract/Free FullText] Iwata, N., Mizukami, H., Shirotani, K., Takaki, Y., Muramatsu, S., Lu, B., Gerard, N. 

Phrase: "276,"

Phrase: "2189521901"

Phrase: "[Abstract/Free FullText"

Phrase: "] Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizukami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Muramatsu,"

Phrase: "S."

Phrase: ","

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.364: P., Gerard, C., Ozawa, K., and Saido, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ozawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.365: C. 

Phrase: "C."
Processing 00000000.tx.366: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.367: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.368: 24, 991998[Abstract/Free FullText] Takaki, Y., Iwata, N., Tsubuki, S., Taniguchi, S., Toyoshima, S., Lu, B., Gerard, N. 

Phrase: "24,"

Phrase: "991998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takaki,"

Phrase: "Y.,"

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Taniguchi,"

Phrase: "S."

Phrase: ","

Phrase: "Toyoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.369: P., Gerard, C., Lee, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.370: J., Shirotani, K., and Saido, T. 

Phrase: "J.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.371: C. 

Phrase: "C."
Processing 00000000.tx.372: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.373: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.374: (Tokyo) 128, 897902[Abstract] Suzuki, N., Cheung, T. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "128,"

Phrase: "897902"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.375: T., Cai, X. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.376: D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.377: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.378: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.379: (1994) Science 264, 13361340[Medline] [OrderarticleviaInfotrieve] Asami-Odaka, A., Ishibashi, Y., Kikuchi, T., Kitada, C., and Suzuki, N. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "13361340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Asami-Odaka,"

Phrase: "A.,"

Phrase: "Ishibashi,"

Phrase: "Y.,"

Phrase: "Kikuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kitada,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.380: (1995) Biochemistry 34, 1027210278[Medline] [OrderarticleviaInfotrieve] Devault, A., Nault, C., Zollinger, M., Fournie-Zaluski, M. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochemistry 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "1027210278"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Devault,"

Phrase: "A.,"

Phrase: "Nault,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zollinger,"

Phrase: "M."

Phrase: ","

Phrase: "Fournie-Zaluski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.381: C., Roques, B. 

Phrase: "C., Roques,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.382: P., Crine, P., and Boileau, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crine,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Boileau,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.383: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.384: Biol. 

Phrase: "Biol."
Processing 00000000.tx.385: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.386: 263, 40334040[Abstract/Free FullText] Cailler, F., Howell, S., and Crine, P. 

Phrase: "263,"

Phrase: "40334040"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cailler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Howell,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Crine,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.387: (1998) Biochim. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.388: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.389: Acta 1415, 19[Medline] [OrderarticleviaInfotrieve] Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H. 

Phrase: "Acta 1415,"

Phrase: "19"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Watanabe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sekiguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Hosoki,"

Phrase: "E.,"

Phrase: "Kawashima-Morishima,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.390: J., Hama, E., Sekine-Aizawa, Y., and Saido, T. 

Phrase: "J.,"

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Sekine-Aizawa,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.391: C. 

Phrase: "C."
Processing 00000000.tx.392: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.393: Med. 

Phrase: "Med."
Processing 00000000.tx.394: 6, 143150[CrossRef][Medline] [OrderarticleviaInfotrieve] Fukami, S., Watanabe, K., Iwata, N., Haraoka, J., Lu, B., Gerard, N. 

Phrase: "6,"

Phrase: "143150"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Fukami,"

Phrase: "S."

Phrase: ","

Phrase: "Watanabe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Haraoka,"

Phrase: "J.,"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.395: P., Gerard, C., Fraser, P., Westaway, D., St. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.396: George-Hyslop, P., and Saido, T. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.397: C. 

Phrase: "C."
Processing 00000000.tx.398: (2002) Neurosci. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.399: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.400: 43, 3956[CrossRef][Medline] [OrderarticleviaInfotrieve] Almeida, C. 

Phrase: "43,"

Phrase: "3956"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Almeida,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463949:Almeida [Eukaryote]

Phrase: "C."
Processing 00000000.tx.401: G., Takahashi, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.402: H., Kearney, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kearney,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.403: F., Yu, F., Li, F., Lin, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.404: T., Greengard, P., Snyder, E., and Gouras, G. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Snyder,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Gouras,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.405: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.406: (2003) Program No. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "No."
Processing 00000000.tx.407: 667.8, Society for Neuroscience, Washington, D. 

Phrase: "667.8,"

Phrase: "Society for Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037455:society [Organization]

Phrase: "Washington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:Washington [Geographic Area]

Phrase: "D."
Processing 00000000.tx.408: C. 

Phrase: "C."
Processing 00000000.tx.409: Iwata, H., Tomita, T., Maruyama, K., and Iwatsubo, T. 

Phrase: "Iwata,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.410: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.411: Biol. 

Phrase: "Biol."
Processing 00000000.tx.412: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.413: 276, 2167821685[Abstract/Free FullText] Chui, D. 

Phrase: "276,"

Phrase: "2167821685"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chui,"

Phrase: "D."
Processing 00000000.tx.414: H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., Takahashi, K., Gallyas, F., and Tabira, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ozawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "S."

Phrase: ","

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Araki,"

Phrase: "W.,"

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gallyas,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Tabira,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.415: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.416: Med. 

Phrase: "Med."
Processing 00000000.tx.417: 5, 560564[CrossRef][Medline] [OrderarticleviaInfotrieve] Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., Pradier, L., Beyreuther, K., and Bayer, T. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "560564"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wirths,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Blanchard,"

Phrase: "V.,"

Phrase: "Moussaoui,"

Phrase: "S."

Phrase: ","

Phrase: "Tremp,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Bayer,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.418: A. 

Phrase: "A."
Processing 00000000.tx.419: (2001) Neurosci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.420: Lett. 

Phrase: "Lett."
Processing 00000000.tx.421: 306, 116120[CrossRef][Medline] [OrderarticleviaInfotrieve] Shie, F. 

Phrase: "306,"

Phrase: "116120"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shie,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.422: S., LeBoeur, R. 

Phrase: "S."

Phrase: ","

Phrase: "LeBoeur,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.423: C., and Jin, L. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Jin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.424: W. 

Phrase: "W."
Processing 00000000.tx.425: (2003) Neuroreport 14, 123129[CrossRef][Medline] [OrderarticleviaInfotrieve] Schmitz, A., Schneider, A., Kummer, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuroreport 14,"

Phrase: "123129"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schmitz,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "A.,"

Phrase: "Kummer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.426: P., and Herzogm, V. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Herzogm,"

Phrase: "V."
Processing 00000000.tx.427: (2004) Traffic 5, 89101[Medline] [OrderarticleviaInfotrieve] Marcel, D., Pollard, H., Verroust, P., Schwartz, J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Traffic 5,"

Phrase: "89101"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marcel,"

Phrase: "D."

Phrase: ","

Phrase: "Pollard,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Verroust,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schwartz,"

Phrase: "J."
Processing 00000000.tx.428: C., and Beaudet, A. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Beaudet,"

Phrase: "A."
Processing 00000000.tx.429: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.430: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.431: 10, 28042817[Abstract] Barnes, K., Turner, A. 

Phrase: "10,"

Phrase: "28042817"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barnes,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.432: J., and Kenny, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Kenny,"

Phrase: "A."
Processing 00000000.tx.433: J. 

Phrase: "J."
Processing 00000000.tx.434: (1993) Neuroscience 53, 10731082[CrossRef][Medline] [OrderarticleviaInfotrieve] Koo, E. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neuroscience 53,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "10731082"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Koo,"

Phrase: "E."
Processing 00000000.tx.435: H., Sisodia, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.436: S., Archer, D. 

Phrase: "S."

Phrase: ","

Phrase: "Archer,"

Phrase: "D."
Processing 00000000.tx.437: R., Martin, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Martin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.438: J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. 

Phrase: "J.,"

Phrase: "Weidemann,"

Phrase: "A.,"

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fischer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.439: L., and Price, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.440: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.441: (1990) Proc. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.442: Natl. 

Phrase: "Natl."
Processing 00000000.tx.443: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.444: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.445: U. 

Phrase: "U."
Processing 00000000.tx.446: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.447: A. 

Phrase: "A."
Processing 00000000.tx.448: 87, 15611565[Abstract] Buxbaum, J. 

Phrase: "87,"

Phrase: "15611565"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Buxbaum,"

Phrase: "J."
Processing 00000000.tx.449: D., Thinakaran, G., Koliatsos, V., O'Callahan, J., Slunt, H. 

Phrase: "D."

Phrase: ","

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Koliatsos,"

Phrase: "V.,"

Phrase: "O'Callahan,"

Phrase: "J.,"

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.450: H., Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.451: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.452: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.453: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.454: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.455: 18, 96299637[Abstract/Free FullText] Yanagisawa, K., Odaka, A., Suzuki, N., and Ihara, Y. 

Phrase: "18,"

Phrase: "96299637"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yanagisawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.456: (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.457: Med. 

Phrase: "Med."
Processing 00000000.tx.458: 1, 10621066[Medline] [OrderarticleviaInfotrieve] Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10621066"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kakio,"

Phrase: "A.,"

Phrase: "Nishimoto,"

Phrase: "S."

Phrase: ","

Phrase: "Yanagisawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kozutsumi,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Matsuzaki,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.459: (2002) Biochemistry 41, 73857390[CrossRef][Medline] [OrderarticleviaInfotrieve] Matsubara, E., Frangione, B., and Ghiso, J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochemistry 41,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "73857390"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matsubara,"

Phrase: "E.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Ghiso,"

Phrase: "J."
Processing 00000000.tx.460: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.461: Biol. 

Phrase: "Biol."
Processing 00000000.tx.462: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.463: 270, 75637567[Abstract/Free FullText] DeMattos, R. 

Phrase: "270,"

Phrase: "75637567"

Phrase: "[Abstract/Free FullText"

Phrase: "] DeMattos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.464: B., O'dell, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "O'dell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.465: A., Parsadanian, M., Taylor, J. 

Phrase: "A.,"

Phrase: "Parsadanian,"

Phrase: "M."

Phrase: ","

Phrase: "Taylor,"

Phrase: "J."
Processing 00000000.tx.466: W., Harmony, J. 

Phrase: "W., Harmony,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0699798:harmony [Social Behavior]
   861   C2945637:harmony [Finding]

Phrase: "J."
Processing 00000000.tx.467: A., Bales, K. 

Phrase: "A.,"

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.468: R., Paul, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.469: M., Aronow, B. 

Phrase: "M."

Phrase: ","

Phrase: "Aronow,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.470: J., and Holtzman, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.471: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.473: Natl. 

Phrase: "Natl."
Processing 00000000.tx.474: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.475: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.476: U. 

Phrase: "U."
Processing 00000000.tx.477: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.478: A. 

Phrase: "A."
Processing 00000000.tx.479: 99, 1084310848[Abstract/Free FullText] Holtzman, D. 

Phrase: "99,"

Phrase: "1084310848"

Phrase: "[Abstract/Free FullText"

Phrase: "] Holtzman,"

Phrase: "D."
Processing 00000000.tx.480: M., Fagan, A. 

Phrase: "M."

Phrase: ","

Phrase: "Fagan,"

Phrase: "A."
Processing 00000000.tx.481: M., Mackey, B., Tenkova, T., Sartorius, L., Paul, S. 

Phrase: "M."

Phrase: ","

Phrase: "Mackey,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tenkova,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sartorius,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0224434:Sartorius [Body Part, Organ, or Organ Component]
  1000   C1305055:Sartorius [Body Part, Organ, or Organ Component]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.482: M., Bales, K., Ashe, K. 

Phrase: "M."

Phrase: ","

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ashe,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.483: H., Irizarry, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.484: C., and Hyman, B. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.485: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.486: (2000) Ann. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.487: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.488: 47, 739747[CrossRef][Medline] [OrderarticleviaInfotrieve] Fagan, A. 

Phrase: "47,"

Phrase: "739747"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Fagan,"

Phrase: "A."
Processing 00000000.tx.489: M., Watson, M., Parsadanian, M., Bales, K. 

Phrase: "M."

Phrase: ","

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Parsadanian,"

Phrase: "M."

Phrase: ","

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.490: R., Paul, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.491: M., and Holtzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.492: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.493: (2002) Neurobiol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.494: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.495: 9, 305318[CrossRef][Medline] [OrderarticleviaInfotrieve] This Article Abstract Full Text (PDF) All Versions of this Article: 279/29/30259 most recent M401891200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Hama, E. 

Phrase: "9,"

Phrase: "305318"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "279/29/30259 most recent M401891200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.496: Articles by Saido, T. 

Phrase: "Articles by Saido,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.497: C. 

Phrase: "C."
Processing 00000000.tx.498: Articles citing this Article PubMed PubMed Citation Articles by Hama, E. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Hama,"

Phrase: "E."
Processing 00000000.tx.499: Articles by Saido, T. 

Phrase: "Articles by Saido,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.500: C. 

Phrase: "C."
Processing 00000000.tx.501: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2004 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2004 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

